| Old | New | Differences | |
|---|---|---|---|
| 1 | - | ||
| 1 | + | CALIFORNIA LEGISLATURE 20172018 REGULAR SESSION Assembly Bill No. 1802Introduced by Assembly Member SalasJanuary 09, 2018 An act to amend Section 3041 of the Business and Professions Code, relating to healing arts. LEGISLATIVE COUNSEL'S DIGESTAB 1802, as introduced, Salas. Optometry: scope of practice.The Optometry Practice Act provides for the licensure and regulation of the practice of optometry by the State Board of Optometry, which is within the Department of Consumer Affairs. That act provides that the practice of optometry includes the prevention and diagnosis of disorders and dysfunctions of the visual system, and the treatment and management of certain disorders and dysfunctions of the visual system, as well as the provision of habilitative or rehabilitative optometric services, and doing certain things, including the examination of the human eye or eyes. Existing law authorizes an optometrist certified to use therapeutic pharmaceutical agents to, among other things, administer immunizations if the optometrist meets certain requirements.This bill would correct an erroneous cross-reference in the provision relating to the authority of an optometrist certified to use therapeutic pharmaceutical agents to administer immunizations, and would make other nonsubstantive changes.Digest Key Vote: MAJORITY Appropriation: NO Fiscal Committee: NO Local Program: NO Bill TextThe people of the State of California do enact as follows:SECTION 1. Section 3041 of the Business and Professions Code is amended to read:3041. (a) The practice of optometry includes the prevention and diagnosis of disorders and dysfunctions of the visual system, and the treatment and management of certain disorders and dysfunctions of the visual system, as well as the provision of habilitative or rehabilitative optometric services, and is the doing of any or all of the following:(1) The examination of the human eye or eyes, or its or their appendages, and the analysis of the human vision system, either subjectively or objectively.(2) The determination of the powers or range of human vision and the accommodative and refractive states of the human eye or eyes, including the scope of its or their functions and general condition.(3) The prescribing or directing the use of, or using, any optical device in connection with ocular exercises, visual training, vision training, or orthoptics.(4) The prescribing of contact and spectacle lenses for, or the fitting or adaptation of contact and spectacle lenses to, the human eye, including lenses that may be classified as drugs or devices by any law of the United States or of this state.(5) The use of topical pharmaceutical agents for the purpose of the examination of the human eye or eyes for any disease or pathological condition.(b) (1) An optometrist who is certified to use therapeutic pharmaceutical agents, pursuant to Section 3041.3, may also diagnose and treat the human eye or eyes, or any of its or their appendages, for all of the following conditions:(A) Through medical treatment, infections of the anterior segment and adnexa, excluding the lacrimal gland, the lacrimal drainage system, and the sclera in patients under 12 years of age.(B) Ocular allergies of the anterior segment and adnexa.(C) Ocular inflammation, nonsurgical in cause except when comanaged with the treating physician and surgeon, limited to inflammation resulting from traumatic iritis, peripheral corneal inflammatory keratitis, episcleritis, and unilateral nonrecurrent nongranulomatous idiopathic iritis in patients over 18 years of age.(D) Traumatic or recurrent conjunctival or corneal abrasions and erosions.(E) Nonmalignant ocular surface disease and dry eye disease.(F) Ocular pain, nonsurgical in cause except when comanaged with the treating physician and surgeon, associated with conditions optometrists are authorized to treat.(G) Hypotrichosis and blepharitis.(H) Pursuant to subdivision (e), glaucoma in patients over 18 years of age, as described in subdivision (j). (k).(2) For purposes of this section, treat means the use of therapeutic pharmaceutical agents, as described in subdivision (c), and the procedures described in subdivision (d).(c) In diagnosing and treating the conditions listed in subdivision (b), an optometrist certified to use therapeutic pharmaceutical agents pursuant to Section 3041.3 may use or prescribe, including for rational off-label purposes, all of the following therapeutic pharmaceutical agents:(1) Topical pharmaceutical agents for the examination of the human eye or eyes for any disease or pathological condition, including, but not limited to, topical miotics.(2) Topical lubricants.(3) Antiallergy agents. In using topical steroid medication for the treatment of ocular allergies, an optometrist shall consult with an ophthalmologist if the patients condition worsens 21 days after diagnosis.(4) Topical and oral anti-inflammatories.(5) Topical antibiotic agents.(6) Topical hyperosmotics.(7) Topical and oral antiglaucoma agents pursuant to the certification process defined in subdivision (e).(8) Nonprescription medications used for the rational treatment of an ocular disorder.(9) Oral antihistamines.(10) Prescription oral nonsteroidal anti-inflammatory agents.(11) Oral antibiotics for medical treatment of ocular disease.(12) Topical and oral antiviral medication for the medical treatment of herpes simplex viral keratitis, herpes simplex viral conjunctivitis, periocular herpes simplex viral dermatitis, varicella zoster viral keratitis, varicella zoster viral conjunctivitis, and periocular varicella zoster viral dermatitis.(13) Oral analgesics that are not controlled substances.(14) Codeine with compounds, hydrocodone with compounds, and tramadol as listed in the California Uniform Controlled Substances Act (Division 10 (commencing with Section 11000) of the Health and Safety Code) and the United States Uniform Controlled Substances Act (21 U.S.C. Sec. 801 et seq.). The use of these agents shall be limited to three days, with a referral to an ophthalmologist if the pain persists.(15) Additional therapeutic pharmaceutical agents pursuant to subdivision (f).(d) An optometrist who is certified to use therapeutic pharmaceutical agents pursuant to Section 3041.3 may also perform all of the following procedures:(1) Corneal scraping with cultures.(2) Debridement of corneal epithelia.(3) Mechanical epilation.(4) Collection of blood by skin puncture or venipuncture for testing patients suspected of having diabetes.(5) Suture removal, with prior consultation with the treating physician and surgeon.(6) Treatment or removal of sebaceous cysts by expression.(7) Administration of oral fluorescein to patients suspected as having diabetic retinopathy.(8) Use of an auto-injector to counter anaphylaxis.(9) Ordering of smears, cultures, sensitivities, complete blood count, mycobacterial culture, acid fast stain, urinalysis, tear fluid analysis, and X-rays necessary for the diagnosis of conditions or diseases of the eye or adnexa. An optometrist may order other types of images subject to prior consultation with an ophthalmologist or appropriate physician and surgeon.(10) A clinical laboratory test or examination classified as waived under the federal Clinical Laboratory Improvement Amendments of 1988 (CLIA) (42 U.S.C. Sec. 263a; Public Law 100-578) and designated as waived in paragraph (9) necessary for the diagnosis of conditions and diseases of the eye or adnexa, or if otherwise specifically authorized by this chapter.(11) Punctal occlusion by plugs, excluding laser, diathermy, cryotherapy, or other means constituting surgery as defined in this chapter.(12) The use or prescription of diagnostic or therapeutic contact lenses, including lenses or devices that incorporate a medication or therapy the optometrist is certified to prescribe or provide.(13) Removal of foreign bodies from the cornea, eyelid, and conjunctiva with any appropriate instrument other than a scalpel. Corneal foreign bodies shall be nonperforating, be no deeper than the midstroma, and require no surgical repair upon removal.(14) For patients over 12 years of age, lacrimal irrigation and dilation, excluding probing of the nasal lacrimal tract. The board shall certify any optometrist who graduated from an accredited school of optometry before May 1, 2000, to perform this procedure after submitting proof of satisfactory completion of 10 procedures under the supervision of an ophthalmologist as confirmed by the ophthalmologist. Any optometrist who graduated from an accredited school of optometry on or after May 1, 2000, shall be exempt from the certification requirement contained in this paragraph.(15) Intravenous injection for the purpose of performing ocular angiography at the direction of an ophthalmologist as part of an active treatment plan in a setting where a physician and surgeon is immediately available.(16) Skin testing to diagnose ocular allergies, limited to the superficial layer of the skin.(17) Use of any noninvasive medical device or technology authorized pursuant to subdivision (f).(e) An optometrist certified pursuant to Section 3041.3 shall be certified for the treatment of glaucoma, as described in subdivision (j), (k), in patients over 18 years of age after the optometrist meets the following applicable requirements:(1) For licensees who graduated from an accredited school of optometry on or after May 1, 2008, submission of proof of graduation from that institution.(2) For licensees who were certified to treat glaucoma under this section prior to before January 1, 2009, submission of proof of completion of that certification program.(3) For licensees who completed a didactic course of not less than 24 hours in the diagnosis, pharmacological, and other treatment and management of glaucoma, submission of proof of satisfactory completion of the case management requirements for certification established by the board.(4) For licensees who graduated from an accredited school of optometry on or before May 1, 2008, and who are not described in paragraph (2) or (3), submission of proof of satisfactory completion of the requirements for certification established by the board under Chapter 352 of the Statutes of 2008.(f) (1) Any topical or oral therapeutic pharmaceutical agent, which is not a controlled substance, or noninvasive medical device or technology that is not expressly authorized for use or prescription by an optometrist certified to use therapeutic pharmaceutical agents pursuant to Section 3041.3 shall be deemed to be authorized if it has received a United States Food and Drug Administration approved indication for the diagnosis or treatment of a condition authorized by this chapter. A licensee shall successfully complete any clinical training imposed by a related manufacturer prior to before using any of those therapeutic pharmaceutical agents or noninvasive medical devices or technologies.(2) Any other topical or oral therapeutic pharmaceutical agent, which is not a controlled substance, or noninvasive medical device or technology that is not expressly authorized for use or prescription by an optometrist certified to use therapeutic pharmaceutical agents pursuant to Section 3041.3 and does not meet the requirements in paragraph (1) shall be deemed authorized if approved by the board through regulation for the rational treatment of a condition authorized by this chapter. Any regulation under this paragraph shall require a licensee to successfully complete an appropriate amount of clinical training to qualify to use each topical or oral therapeutic pharmaceutical agent or noninvasive medical device or technology approved by the board pursuant to this paragraph.(3) This subdivision shall not be construed to authorize any of the following:(A) Any therapeutic pharmaceutical agent, medical device, or technology involving cutting, altering, or otherwise infiltrating human tissue by any means.(B) A clinical laboratory test or imaging study not authorized by paragraphs (1) to (16), inclusive, of subdivision (d).(C) Treatment of any disease or condition that could not be treated by an optometrist before January 1, 2018.(g) (1) An optometrist certified pursuant to Section 3014.3 3041.3 shall be certified for the administration of immunizations after the optometrist meets all of the following requirements:(A) Completes an immunization training program endorsed by the federal Centers for Disease Control and Prevention (CDC) that, at a minimum, includes hands-on injection technique, clinical evaluation of indications and contradications of vaccines, and the recognition and treatment of emergency reactions to vaccines, and maintains that training.(B) Is certified in basic life support.(C) Complies with all state and federal recordkeeping and reporting requirements, including providing documentation to the patients primary care provided and entering information in the appropriate immunization registry designated by the immunization branch of the State Department of Public Health.(D) Applies for an immunization certificate on a board-approved form.(2) For the purposes of this section, immunization means the administration of immunizations for influenza, herpes zoster virus, and pneumococcus in compliance with individual Advisory Committee on Immunization Practices (ACIP) vaccine recommendations published by the CDC for persons 18 years of age or older.(h) Other than for prescription ophthalmic devices described in subdivision (b) of Section 2541, any dispensing of a therapeutic pharmaceutical agent by an optometrist shall be without charge.(i) The practice of optometry does not include performing surgery. Surgery means any procedure in which human tissue is cut, altered, or otherwise infiltrated by mechanical or laser means. Surgery does not include those procedures specified in paragraphs (1) to (15), inclusive, of subdivision (d). This subdivision does not limit an optometrists authority to utilize diagnostic laser and ultrasound technology within his or her scope of practice.(j) An optometrist licensed under this chapter is subject to the provisions of Section 2290.5 for purposes of practicing telehealth.(k) For purposes of this chapter, glaucoma means either of the following:(1) All primary open-angle glaucoma.(2) Exfoliation and pigmentary glaucoma.(3) (A) Steroid induced glaucoma.(B) If an optometrist treats a patient for steroid induced glaucoma the optometrist shall promptly notify the prescriber of the steroid medication if the prescriber did not refer the patient to the optometrist for treatment.(l) For purposes of this chapter, adnexa means ocular adnexa.(m) In an emergency, an optometrist shall stabilize, if possible, and immediately refer any patient who has an acute attack of angle closure to an ophthalmologist. | |
| 2 | 2 | ||
| 3 | - | ||
| 3 | + | CALIFORNIA LEGISLATURE 20172018 REGULAR SESSION Assembly Bill No. 1802Introduced by Assembly Member SalasJanuary 09, 2018 An act to amend Section 3041 of the Business and Professions Code, relating to healing arts. LEGISLATIVE COUNSEL'S DIGESTAB 1802, as introduced, Salas. Optometry: scope of practice.The Optometry Practice Act provides for the licensure and regulation of the practice of optometry by the State Board of Optometry, which is within the Department of Consumer Affairs. That act provides that the practice of optometry includes the prevention and diagnosis of disorders and dysfunctions of the visual system, and the treatment and management of certain disorders and dysfunctions of the visual system, as well as the provision of habilitative or rehabilitative optometric services, and doing certain things, including the examination of the human eye or eyes. Existing law authorizes an optometrist certified to use therapeutic pharmaceutical agents to, among other things, administer immunizations if the optometrist meets certain requirements.This bill would correct an erroneous cross-reference in the provision relating to the authority of an optometrist certified to use therapeutic pharmaceutical agents to administer immunizations, and would make other nonsubstantive changes.Digest Key Vote: MAJORITY Appropriation: NO Fiscal Committee: NO Local Program: NO | |
| 4 | 4 | ||
| 5 | - | Amended IN Senate June 14, 2018 | |
| 6 | 5 | ||
| 7 | - | Amended IN Senate June 14, 2018 | |
| 6 | + | ||
| 7 | + | ||
| 8 | 8 | ||
| 9 | 9 | CALIFORNIA LEGISLATURE 20172018 REGULAR SESSION | |
| 10 | 10 | ||
| 11 | 11 | Assembly Bill No. 1802 | |
| 12 | 12 | ||
| 13 | 13 | Introduced by Assembly Member SalasJanuary 09, 2018 | |
| 14 | 14 | ||
| 15 | 15 | Introduced by Assembly Member Salas | |
| 16 | 16 | January 09, 2018 | |
| 17 | 17 | ||
| 18 | - | An act to amend Section 3041 | |
| 18 | + | An act to amend Section 3041 of the Business and Professions Code, relating to healing arts. | |
| 19 | 19 | ||
| 20 | 20 | LEGISLATIVE COUNSEL'S DIGEST | |
| 21 | 21 | ||
| 22 | 22 | ## LEGISLATIVE COUNSEL'S DIGEST | |
| 23 | 23 | ||
| 24 | - | AB 1802, as | |
| 24 | + | AB 1802, as introduced, Salas. Optometry: scope of practice. | |
| 25 | 25 | ||
| 26 | - | Existing law provides for the licensure and regulation of the practice of optometry by the State Board of Optometry, which is within the Department of Consumer Affairs, and also makes the board responsible for the regulation of registered dispensing opticians. Under existing law, a dispensing optician is an individual, corporation, or firm engaged in the business of filling prescriptions of physicians and surgeons licensed by the Medical Board of California or optometrists licensed by the State Board of Optometry for prescription lenses and kindred products, and, as incidental to the filling of those prescriptions, doing any or all of the following acts, either singly or in combination with others, taking facial measurements, fitting and adjusting those lenses, and fitting and adjusting spectacle frames. Existing law prohibits an optometrist from having any membership proprietary interest, coownership, or any profit-sharing arrangement, either by stock ownership, interlocking directors, trusteeship, mortgage, or trust deed, with any registered dispensing optician or any optical company, except as specified, and makes a violation of this provision punishable by a fine. Existing law defines a registered dispensing optician, for these purposes, as a person licensed by the board. Under existing law, any person who participates with a licensed optometrist in violation of these provisions is guilty of a misdemeanor.This bill would instead prohibit an optometrist from having any of those above-described arrangements with a dispensing optician or optical company, except as specified, and would define dispensing optician as an individual, corporation, or firm engaged in the business of filling prescriptions of physicians and surgeons licensed by the Medical Board of California or optometrists licensed by the State Board of Optometry for prescription lenses and kindred products, and, as incidental to the filling of those prescriptions, doing any or all of the following acts, either singly or in combination with others, taking facial measurements, fitting and adjusting those lenses, and fitting and adjusting spectacle frames, regardless of whether the individual, corporation, or firm is registered by the State Board of Optometry. By changing the definition of an existing crime, this bill would result in a state-mandated local program.The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.This bill would provide that no reimbursement is required by this act for a specified reason.The Optometry Practice Act provides for the licensure and regulation of the practice of optometry by the State Board of Optometry, which is within the Department of Consumer Affairs. That act provides that the practice of optometry includes the prevention and diagnosis of disorders and dysfunctions of the visual system, and the treatment and management of certain disorders and dysfunctions of the visual system, as well as the provision of habilitative or rehabilitative optometric services, and doing certain things, including the examination of the human eye or eyes. Existing law authorizes an optometrist certified to use therapeutic pharmaceutical agents to, among other things, administer immunizations if the optometrist meets certain requirements.This bill would correct an erroneous cross-reference in the provision relating to the authority of an optometrist certified to use therapeutic pharmaceutical agents to administer immunizations, and would make other nonsubstantive changes. | |
| 27 | - | ||
| 28 | - | Existing law provides for the licensure and regulation of the practice of optometry by the State Board of Optometry, which is within the Department of Consumer Affairs, and also makes the board responsible for the regulation of registered dispensing opticians. Under existing law, a dispensing optician is an individual, corporation, or firm engaged in the business of filling prescriptions of physicians and surgeons licensed by the Medical Board of California or optometrists licensed by the State Board of Optometry for prescription lenses and kindred products, and, as incidental to the filling of those prescriptions, doing any or all of the following acts, either singly or in combination with others, taking facial measurements, fitting and adjusting those lenses, and fitting and adjusting spectacle frames. | |
| 29 | - | ||
| 30 | - | Existing law prohibits an optometrist from having any membership proprietary interest, coownership, or any profit-sharing arrangement, either by stock ownership, interlocking directors, trusteeship, mortgage, or trust deed, with any registered dispensing optician or any optical company, except as specified, and makes a violation of this provision punishable by a fine. Existing law defines a registered dispensing optician, for these purposes, as a person licensed by the board. Under existing law, any person who participates with a licensed optometrist in violation of these provisions is guilty of a misdemeanor. | |
| 31 | - | ||
| 32 | - | This bill would instead prohibit an optometrist from having any of those above-described arrangements with a dispensing optician or optical company, except as specified, and would define dispensing optician as an individual, corporation, or firm engaged in the business of filling prescriptions of physicians and surgeons licensed by the Medical Board of California or optometrists licensed by the State Board of Optometry for prescription lenses and kindred products, and, as incidental to the filling of those prescriptions, doing any or all of the following acts, either singly or in combination with others, taking facial measurements, fitting and adjusting those lenses, and fitting and adjusting spectacle frames, regardless of whether the individual, corporation, or firm is registered by the State Board of Optometry. By changing the definition of an existing crime, this bill would result in a state-mandated local program. | |
| 33 | - | ||
| 34 | - | The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement. | |
| 35 | - | ||
| 36 | - | This bill would provide that no reimbursement is required by this act for a specified reason. | |
| 26 | + | The Optometry Practice Act provides for the licensure and regulation of the practice of optometry by the State Board of Optometry, which is within the Department of Consumer Affairs. That act provides that the practice of optometry includes the prevention and diagnosis of disorders and dysfunctions of the visual system, and the treatment and management of certain disorders and dysfunctions of the visual system, as well as the provision of habilitative or rehabilitative optometric services, and doing certain things, including the examination of the human eye or eyes. Existing law authorizes an optometrist certified to use therapeutic pharmaceutical agents to, among other things, administer immunizations if the optometrist meets certain requirements.This bill would correct an erroneous cross-reference in the provision relating to the authority of an optometrist certified to use therapeutic pharmaceutical agents to administer immunizations, and would make other nonsubstantive changes. | |
| 37 | 27 | ||
| 38 | 28 | The Optometry Practice Act provides for the licensure and regulation of the practice of optometry by the State Board of Optometry, which is within the Department of Consumer Affairs. That act provides that the practice of optometry includes the prevention and diagnosis of disorders and dysfunctions of the visual system, and the treatment and management of certain disorders and dysfunctions of the visual system, as well as the provision of habilitative or rehabilitative optometric services, and doing certain things, including the examination of the human eye or eyes. Existing law authorizes an optometrist certified to use therapeutic pharmaceutical agents to, among other things, administer immunizations if the optometrist meets certain requirements. | |
| 39 | 29 | ||
| 40 | - | ||
| 41 | - | ||
| 42 | 30 | This bill would correct an erroneous cross-reference in the provision relating to the authority of an optometrist certified to use therapeutic pharmaceutical agents to administer immunizations, and would make other nonsubstantive changes. | |
| 43 | - | ||
| 44 | - | ||
| 45 | 31 | ||
| 46 | 32 | ## Digest Key | |
| 47 | 33 | ||
| 48 | 34 | ## Bill Text | |
| 49 | 35 | ||
| 50 | - | The people of the State of California do enact as follows:SECTION 1. Section | |
| 36 | + | The people of the State of California do enact as follows:SECTION 1. Section 3041 of the Business and Professions Code is amended to read:3041. (a) The practice of optometry includes the prevention and diagnosis of disorders and dysfunctions of the visual system, and the treatment and management of certain disorders and dysfunctions of the visual system, as well as the provision of habilitative or rehabilitative optometric services, and is the doing of any or all of the following:(1) The examination of the human eye or eyes, or its or their appendages, and the analysis of the human vision system, either subjectively or objectively.(2) The determination of the powers or range of human vision and the accommodative and refractive states of the human eye or eyes, including the scope of its or their functions and general condition.(3) The prescribing or directing the use of, or using, any optical device in connection with ocular exercises, visual training, vision training, or orthoptics.(4) The prescribing of contact and spectacle lenses for, or the fitting or adaptation of contact and spectacle lenses to, the human eye, including lenses that may be classified as drugs or devices by any law of the United States or of this state.(5) The use of topical pharmaceutical agents for the purpose of the examination of the human eye or eyes for any disease or pathological condition.(b) (1) An optometrist who is certified to use therapeutic pharmaceutical agents, pursuant to Section 3041.3, may also diagnose and treat the human eye or eyes, or any of its or their appendages, for all of the following conditions:(A) Through medical treatment, infections of the anterior segment and adnexa, excluding the lacrimal gland, the lacrimal drainage system, and the sclera in patients under 12 years of age.(B) Ocular allergies of the anterior segment and adnexa.(C) Ocular inflammation, nonsurgical in cause except when comanaged with the treating physician and surgeon, limited to inflammation resulting from traumatic iritis, peripheral corneal inflammatory keratitis, episcleritis, and unilateral nonrecurrent nongranulomatous idiopathic iritis in patients over 18 years of age.(D) Traumatic or recurrent conjunctival or corneal abrasions and erosions.(E) Nonmalignant ocular surface disease and dry eye disease.(F) Ocular pain, nonsurgical in cause except when comanaged with the treating physician and surgeon, associated with conditions optometrists are authorized to treat.(G) Hypotrichosis and blepharitis.(H) Pursuant to subdivision (e), glaucoma in patients over 18 years of age, as described in subdivision (j). (k).(2) For purposes of this section, treat means the use of therapeutic pharmaceutical agents, as described in subdivision (c), and the procedures described in subdivision (d).(c) In diagnosing and treating the conditions listed in subdivision (b), an optometrist certified to use therapeutic pharmaceutical agents pursuant to Section 3041.3 may use or prescribe, including for rational off-label purposes, all of the following therapeutic pharmaceutical agents:(1) Topical pharmaceutical agents for the examination of the human eye or eyes for any disease or pathological condition, including, but not limited to, topical miotics.(2) Topical lubricants.(3) Antiallergy agents. In using topical steroid medication for the treatment of ocular allergies, an optometrist shall consult with an ophthalmologist if the patients condition worsens 21 days after diagnosis.(4) Topical and oral anti-inflammatories.(5) Topical antibiotic agents.(6) Topical hyperosmotics.(7) Topical and oral antiglaucoma agents pursuant to the certification process defined in subdivision (e).(8) Nonprescription medications used for the rational treatment of an ocular disorder.(9) Oral antihistamines.(10) Prescription oral nonsteroidal anti-inflammatory agents.(11) Oral antibiotics for medical treatment of ocular disease.(12) Topical and oral antiviral medication for the medical treatment of herpes simplex viral keratitis, herpes simplex viral conjunctivitis, periocular herpes simplex viral dermatitis, varicella zoster viral keratitis, varicella zoster viral conjunctivitis, and periocular varicella zoster viral dermatitis.(13) Oral analgesics that are not controlled substances.(14) Codeine with compounds, hydrocodone with compounds, and tramadol as listed in the California Uniform Controlled Substances Act (Division 10 (commencing with Section 11000) of the Health and Safety Code) and the United States Uniform Controlled Substances Act (21 U.S.C. Sec. 801 et seq.). The use of these agents shall be limited to three days, with a referral to an ophthalmologist if the pain persists.(15) Additional therapeutic pharmaceutical agents pursuant to subdivision (f).(d) An optometrist who is certified to use therapeutic pharmaceutical agents pursuant to Section 3041.3 may also perform all of the following procedures:(1) Corneal scraping with cultures.(2) Debridement of corneal epithelia.(3) Mechanical epilation.(4) Collection of blood by skin puncture or venipuncture for testing patients suspected of having diabetes.(5) Suture removal, with prior consultation with the treating physician and surgeon.(6) Treatment or removal of sebaceous cysts by expression.(7) Administration of oral fluorescein to patients suspected as having diabetic retinopathy.(8) Use of an auto-injector to counter anaphylaxis.(9) Ordering of smears, cultures, sensitivities, complete blood count, mycobacterial culture, acid fast stain, urinalysis, tear fluid analysis, and X-rays necessary for the diagnosis of conditions or diseases of the eye or adnexa. An optometrist may order other types of images subject to prior consultation with an ophthalmologist or appropriate physician and surgeon.(10) A clinical laboratory test or examination classified as waived under the federal Clinical Laboratory Improvement Amendments of 1988 (CLIA) (42 U.S.C. Sec. 263a; Public Law 100-578) and designated as waived in paragraph (9) necessary for the diagnosis of conditions and diseases of the eye or adnexa, or if otherwise specifically authorized by this chapter.(11) Punctal occlusion by plugs, excluding laser, diathermy, cryotherapy, or other means constituting surgery as defined in this chapter.(12) The use or prescription of diagnostic or therapeutic contact lenses, including lenses or devices that incorporate a medication or therapy the optometrist is certified to prescribe or provide.(13) Removal of foreign bodies from the cornea, eyelid, and conjunctiva with any appropriate instrument other than a scalpel. Corneal foreign bodies shall be nonperforating, be no deeper than the midstroma, and require no surgical repair upon removal.(14) For patients over 12 years of age, lacrimal irrigation and dilation, excluding probing of the nasal lacrimal tract. The board shall certify any optometrist who graduated from an accredited school of optometry before May 1, 2000, to perform this procedure after submitting proof of satisfactory completion of 10 procedures under the supervision of an ophthalmologist as confirmed by the ophthalmologist. Any optometrist who graduated from an accredited school of optometry on or after May 1, 2000, shall be exempt from the certification requirement contained in this paragraph.(15) Intravenous injection for the purpose of performing ocular angiography at the direction of an ophthalmologist as part of an active treatment plan in a setting where a physician and surgeon is immediately available.(16) Skin testing to diagnose ocular allergies, limited to the superficial layer of the skin.(17) Use of any noninvasive medical device or technology authorized pursuant to subdivision (f).(e) An optometrist certified pursuant to Section 3041.3 shall be certified for the treatment of glaucoma, as described in subdivision (j), (k), in patients over 18 years of age after the optometrist meets the following applicable requirements:(1) For licensees who graduated from an accredited school of optometry on or after May 1, 2008, submission of proof of graduation from that institution.(2) For licensees who were certified to treat glaucoma under this section prior to before January 1, 2009, submission of proof of completion of that certification program.(3) For licensees who completed a didactic course of not less than 24 hours in the diagnosis, pharmacological, and other treatment and management of glaucoma, submission of proof of satisfactory completion of the case management requirements for certification established by the board.(4) For licensees who graduated from an accredited school of optometry on or before May 1, 2008, and who are not described in paragraph (2) or (3), submission of proof of satisfactory completion of the requirements for certification established by the board under Chapter 352 of the Statutes of 2008.(f) (1) Any topical or oral therapeutic pharmaceutical agent, which is not a controlled substance, or noninvasive medical device or technology that is not expressly authorized for use or prescription by an optometrist certified to use therapeutic pharmaceutical agents pursuant to Section 3041.3 shall be deemed to be authorized if it has received a United States Food and Drug Administration approved indication for the diagnosis or treatment of a condition authorized by this chapter. A licensee shall successfully complete any clinical training imposed by a related manufacturer prior to before using any of those therapeutic pharmaceutical agents or noninvasive medical devices or technologies.(2) Any other topical or oral therapeutic pharmaceutical agent, which is not a controlled substance, or noninvasive medical device or technology that is not expressly authorized for use or prescription by an optometrist certified to use therapeutic pharmaceutical agents pursuant to Section 3041.3 and does not meet the requirements in paragraph (1) shall be deemed authorized if approved by the board through regulation for the rational treatment of a condition authorized by this chapter. Any regulation under this paragraph shall require a licensee to successfully complete an appropriate amount of clinical training to qualify to use each topical or oral therapeutic pharmaceutical agent or noninvasive medical device or technology approved by the board pursuant to this paragraph.(3) This subdivision shall not be construed to authorize any of the following:(A) Any therapeutic pharmaceutical agent, medical device, or technology involving cutting, altering, or otherwise infiltrating human tissue by any means.(B) A clinical laboratory test or imaging study not authorized by paragraphs (1) to (16), inclusive, of subdivision (d).(C) Treatment of any disease or condition that could not be treated by an optometrist before January 1, 2018.(g) (1) An optometrist certified pursuant to Section 3014.3 3041.3 shall be certified for the administration of immunizations after the optometrist meets all of the following requirements:(A) Completes an immunization training program endorsed by the federal Centers for Disease Control and Prevention (CDC) that, at a minimum, includes hands-on injection technique, clinical evaluation of indications and contradications of vaccines, and the recognition and treatment of emergency reactions to vaccines, and maintains that training.(B) Is certified in basic life support.(C) Complies with all state and federal recordkeeping and reporting requirements, including providing documentation to the patients primary care provided and entering information in the appropriate immunization registry designated by the immunization branch of the State Department of Public Health.(D) Applies for an immunization certificate on a board-approved form.(2) For the purposes of this section, immunization means the administration of immunizations for influenza, herpes zoster virus, and pneumococcus in compliance with individual Advisory Committee on Immunization Practices (ACIP) vaccine recommendations published by the CDC for persons 18 years of age or older.(h) Other than for prescription ophthalmic devices described in subdivision (b) of Section 2541, any dispensing of a therapeutic pharmaceutical agent by an optometrist shall be without charge.(i) The practice of optometry does not include performing surgery. Surgery means any procedure in which human tissue is cut, altered, or otherwise infiltrated by mechanical or laser means. Surgery does not include those procedures specified in paragraphs (1) to (15), inclusive, of subdivision (d). This subdivision does not limit an optometrists authority to utilize diagnostic laser and ultrasound technology within his or her scope of practice.(j) An optometrist licensed under this chapter is subject to the provisions of Section 2290.5 for purposes of practicing telehealth.(k) For purposes of this chapter, glaucoma means either of the following:(1) All primary open-angle glaucoma.(2) Exfoliation and pigmentary glaucoma.(3) (A) Steroid induced glaucoma.(B) If an optometrist treats a patient for steroid induced glaucoma the optometrist shall promptly notify the prescriber of the steroid medication if the prescriber did not refer the patient to the optometrist for treatment.(l) For purposes of this chapter, adnexa means ocular adnexa.(m) In an emergency, an optometrist shall stabilize, if possible, and immediately refer any patient who has an acute attack of angle closure to an ophthalmologist. | |
| 51 | 37 | ||
| 52 | 38 | The people of the State of California do enact as follows: | |
| 53 | 39 | ||
| 54 | 40 | ## The people of the State of California do enact as follows: | |
| 55 | 41 | ||
| 56 | - | SECTION 1. Section | |
| 42 | + | SECTION 1. Section 3041 of the Business and Professions Code is amended to read:3041. (a) The practice of optometry includes the prevention and diagnosis of disorders and dysfunctions of the visual system, and the treatment and management of certain disorders and dysfunctions of the visual system, as well as the provision of habilitative or rehabilitative optometric services, and is the doing of any or all of the following:(1) The examination of the human eye or eyes, or its or their appendages, and the analysis of the human vision system, either subjectively or objectively.(2) The determination of the powers or range of human vision and the accommodative and refractive states of the human eye or eyes, including the scope of its or their functions and general condition.(3) The prescribing or directing the use of, or using, any optical device in connection with ocular exercises, visual training, vision training, or orthoptics.(4) The prescribing of contact and spectacle lenses for, or the fitting or adaptation of contact and spectacle lenses to, the human eye, including lenses that may be classified as drugs or devices by any law of the United States or of this state.(5) The use of topical pharmaceutical agents for the purpose of the examination of the human eye or eyes for any disease or pathological condition.(b) (1) An optometrist who is certified to use therapeutic pharmaceutical agents, pursuant to Section 3041.3, may also diagnose and treat the human eye or eyes, or any of its or their appendages, for all of the following conditions:(A) Through medical treatment, infections of the anterior segment and adnexa, excluding the lacrimal gland, the lacrimal drainage system, and the sclera in patients under 12 years of age.(B) Ocular allergies of the anterior segment and adnexa.(C) Ocular inflammation, nonsurgical in cause except when comanaged with the treating physician and surgeon, limited to inflammation resulting from traumatic iritis, peripheral corneal inflammatory keratitis, episcleritis, and unilateral nonrecurrent nongranulomatous idiopathic iritis in patients over 18 years of age.(D) Traumatic or recurrent conjunctival or corneal abrasions and erosions.(E) Nonmalignant ocular surface disease and dry eye disease.(F) Ocular pain, nonsurgical in cause except when comanaged with the treating physician and surgeon, associated with conditions optometrists are authorized to treat.(G) Hypotrichosis and blepharitis.(H) Pursuant to subdivision (e), glaucoma in patients over 18 years of age, as described in subdivision (j). (k).(2) For purposes of this section, treat means the use of therapeutic pharmaceutical agents, as described in subdivision (c), and the procedures described in subdivision (d).(c) In diagnosing and treating the conditions listed in subdivision (b), an optometrist certified to use therapeutic pharmaceutical agents pursuant to Section 3041.3 may use or prescribe, including for rational off-label purposes, all of the following therapeutic pharmaceutical agents:(1) Topical pharmaceutical agents for the examination of the human eye or eyes for any disease or pathological condition, including, but not limited to, topical miotics.(2) Topical lubricants.(3) Antiallergy agents. In using topical steroid medication for the treatment of ocular allergies, an optometrist shall consult with an ophthalmologist if the patients condition worsens 21 days after diagnosis.(4) Topical and oral anti-inflammatories.(5) Topical antibiotic agents.(6) Topical hyperosmotics.(7) Topical and oral antiglaucoma agents pursuant to the certification process defined in subdivision (e).(8) Nonprescription medications used for the rational treatment of an ocular disorder.(9) Oral antihistamines.(10) Prescription oral nonsteroidal anti-inflammatory agents.(11) Oral antibiotics for medical treatment of ocular disease.(12) Topical and oral antiviral medication for the medical treatment of herpes simplex viral keratitis, herpes simplex viral conjunctivitis, periocular herpes simplex viral dermatitis, varicella zoster viral keratitis, varicella zoster viral conjunctivitis, and periocular varicella zoster viral dermatitis.(13) Oral analgesics that are not controlled substances.(14) Codeine with compounds, hydrocodone with compounds, and tramadol as listed in the California Uniform Controlled Substances Act (Division 10 (commencing with Section 11000) of the Health and Safety Code) and the United States Uniform Controlled Substances Act (21 U.S.C. Sec. 801 et seq.). The use of these agents shall be limited to three days, with a referral to an ophthalmologist if the pain persists.(15) Additional therapeutic pharmaceutical agents pursuant to subdivision (f).(d) An optometrist who is certified to use therapeutic pharmaceutical agents pursuant to Section 3041.3 may also perform all of the following procedures:(1) Corneal scraping with cultures.(2) Debridement of corneal epithelia.(3) Mechanical epilation.(4) Collection of blood by skin puncture or venipuncture for testing patients suspected of having diabetes.(5) Suture removal, with prior consultation with the treating physician and surgeon.(6) Treatment or removal of sebaceous cysts by expression.(7) Administration of oral fluorescein to patients suspected as having diabetic retinopathy.(8) Use of an auto-injector to counter anaphylaxis.(9) Ordering of smears, cultures, sensitivities, complete blood count, mycobacterial culture, acid fast stain, urinalysis, tear fluid analysis, and X-rays necessary for the diagnosis of conditions or diseases of the eye or adnexa. An optometrist may order other types of images subject to prior consultation with an ophthalmologist or appropriate physician and surgeon.(10) A clinical laboratory test or examination classified as waived under the federal Clinical Laboratory Improvement Amendments of 1988 (CLIA) (42 U.S.C. Sec. 263a; Public Law 100-578) and designated as waived in paragraph (9) necessary for the diagnosis of conditions and diseases of the eye or adnexa, or if otherwise specifically authorized by this chapter.(11) Punctal occlusion by plugs, excluding laser, diathermy, cryotherapy, or other means constituting surgery as defined in this chapter.(12) The use or prescription of diagnostic or therapeutic contact lenses, including lenses or devices that incorporate a medication or therapy the optometrist is certified to prescribe or provide.(13) Removal of foreign bodies from the cornea, eyelid, and conjunctiva with any appropriate instrument other than a scalpel. Corneal foreign bodies shall be nonperforating, be no deeper than the midstroma, and require no surgical repair upon removal.(14) For patients over 12 years of age, lacrimal irrigation and dilation, excluding probing of the nasal lacrimal tract. The board shall certify any optometrist who graduated from an accredited school of optometry before May 1, 2000, to perform this procedure after submitting proof of satisfactory completion of 10 procedures under the supervision of an ophthalmologist as confirmed by the ophthalmologist. Any optometrist who graduated from an accredited school of optometry on or after May 1, 2000, shall be exempt from the certification requirement contained in this paragraph.(15) Intravenous injection for the purpose of performing ocular angiography at the direction of an ophthalmologist as part of an active treatment plan in a setting where a physician and surgeon is immediately available.(16) Skin testing to diagnose ocular allergies, limited to the superficial layer of the skin.(17) Use of any noninvasive medical device or technology authorized pursuant to subdivision (f).(e) An optometrist certified pursuant to Section 3041.3 shall be certified for the treatment of glaucoma, as described in subdivision (j), (k), in patients over 18 years of age after the optometrist meets the following applicable requirements:(1) For licensees who graduated from an accredited school of optometry on or after May 1, 2008, submission of proof of graduation from that institution.(2) For licensees who were certified to treat glaucoma under this section prior to before January 1, 2009, submission of proof of completion of that certification program.(3) For licensees who completed a didactic course of not less than 24 hours in the diagnosis, pharmacological, and other treatment and management of glaucoma, submission of proof of satisfactory completion of the case management requirements for certification established by the board.(4) For licensees who graduated from an accredited school of optometry on or before May 1, 2008, and who are not described in paragraph (2) or (3), submission of proof of satisfactory completion of the requirements for certification established by the board under Chapter 352 of the Statutes of 2008.(f) (1) Any topical or oral therapeutic pharmaceutical agent, which is not a controlled substance, or noninvasive medical device or technology that is not expressly authorized for use or prescription by an optometrist certified to use therapeutic pharmaceutical agents pursuant to Section 3041.3 shall be deemed to be authorized if it has received a United States Food and Drug Administration approved indication for the diagnosis or treatment of a condition authorized by this chapter. A licensee shall successfully complete any clinical training imposed by a related manufacturer prior to before using any of those therapeutic pharmaceutical agents or noninvasive medical devices or technologies.(2) Any other topical or oral therapeutic pharmaceutical agent, which is not a controlled substance, or noninvasive medical device or technology that is not expressly authorized for use or prescription by an optometrist certified to use therapeutic pharmaceutical agents pursuant to Section 3041.3 and does not meet the requirements in paragraph (1) shall be deemed authorized if approved by the board through regulation for the rational treatment of a condition authorized by this chapter. Any regulation under this paragraph shall require a licensee to successfully complete an appropriate amount of clinical training to qualify to use each topical or oral therapeutic pharmaceutical agent or noninvasive medical device or technology approved by the board pursuant to this paragraph.(3) This subdivision shall not be construed to authorize any of the following:(A) Any therapeutic pharmaceutical agent, medical device, or technology involving cutting, altering, or otherwise infiltrating human tissue by any means.(B) A clinical laboratory test or imaging study not authorized by paragraphs (1) to (16), inclusive, of subdivision (d).(C) Treatment of any disease or condition that could not be treated by an optometrist before January 1, 2018.(g) (1) An optometrist certified pursuant to Section 3014.3 3041.3 shall be certified for the administration of immunizations after the optometrist meets all of the following requirements:(A) Completes an immunization training program endorsed by the federal Centers for Disease Control and Prevention (CDC) that, at a minimum, includes hands-on injection technique, clinical evaluation of indications and contradications of vaccines, and the recognition and treatment of emergency reactions to vaccines, and maintains that training.(B) Is certified in basic life support.(C) Complies with all state and federal recordkeeping and reporting requirements, including providing documentation to the patients primary care provided and entering information in the appropriate immunization registry designated by the immunization branch of the State Department of Public Health.(D) Applies for an immunization certificate on a board-approved form.(2) For the purposes of this section, immunization means the administration of immunizations for influenza, herpes zoster virus, and pneumococcus in compliance with individual Advisory Committee on Immunization Practices (ACIP) vaccine recommendations published by the CDC for persons 18 years of age or older.(h) Other than for prescription ophthalmic devices described in subdivision (b) of Section 2541, any dispensing of a therapeutic pharmaceutical agent by an optometrist shall be without charge.(i) The practice of optometry does not include performing surgery. Surgery means any procedure in which human tissue is cut, altered, or otherwise infiltrated by mechanical or laser means. Surgery does not include those procedures specified in paragraphs (1) to (15), inclusive, of subdivision (d). This subdivision does not limit an optometrists authority to utilize diagnostic laser and ultrasound technology within his or her scope of practice.(j) An optometrist licensed under this chapter is subject to the provisions of Section 2290.5 for purposes of practicing telehealth.(k) For purposes of this chapter, glaucoma means either of the following:(1) All primary open-angle glaucoma.(2) Exfoliation and pigmentary glaucoma.(3) (A) Steroid induced glaucoma.(B) If an optometrist treats a patient for steroid induced glaucoma the optometrist shall promptly notify the prescriber of the steroid medication if the prescriber did not refer the patient to the optometrist for treatment.(l) For purposes of this chapter, adnexa means ocular adnexa.(m) In an emergency, an optometrist shall stabilize, if possible, and immediately refer any patient who has an acute attack of angle closure to an ophthalmologist. | |
| 57 | 43 | ||
| 58 | - | SECTION 1. Section | |
| 44 | + | SECTION 1. Section 3041 of the Business and Professions Code is amended to read: | |
| 59 | 45 | ||
| 60 | 46 | ### SECTION 1. | |
| 61 | 47 | ||
| 62 | - | ||
| 48 | + | 3041. (a) The practice of optometry includes the prevention and diagnosis of disorders and dysfunctions of the visual system, and the treatment and management of certain disorders and dysfunctions of the visual system, as well as the provision of habilitative or rehabilitative optometric services, and is the doing of any or all of the following:(1) The examination of the human eye or eyes, or its or their appendages, and the analysis of the human vision system, either subjectively or objectively.(2) The determination of the powers or range of human vision and the accommodative and refractive states of the human eye or eyes, including the scope of its or their functions and general condition.(3) The prescribing or directing the use of, or using, any optical device in connection with ocular exercises, visual training, vision training, or orthoptics.(4) The prescribing of contact and spectacle lenses for, or the fitting or adaptation of contact and spectacle lenses to, the human eye, including lenses that may be classified as drugs or devices by any law of the United States or of this state.(5) The use of topical pharmaceutical agents for the purpose of the examination of the human eye or eyes for any disease or pathological condition.(b) (1) An optometrist who is certified to use therapeutic pharmaceutical agents, pursuant to Section 3041.3, may also diagnose and treat the human eye or eyes, or any of its or their appendages, for all of the following conditions:(A) Through medical treatment, infections of the anterior segment and adnexa, excluding the lacrimal gland, the lacrimal drainage system, and the sclera in patients under 12 years of age.(B) Ocular allergies of the anterior segment and adnexa.(C) Ocular inflammation, nonsurgical in cause except when comanaged with the treating physician and surgeon, limited to inflammation resulting from traumatic iritis, peripheral corneal inflammatory keratitis, episcleritis, and unilateral nonrecurrent nongranulomatous idiopathic iritis in patients over 18 years of age.(D) Traumatic or recurrent conjunctival or corneal abrasions and erosions.(E) Nonmalignant ocular surface disease and dry eye disease.(F) Ocular pain, nonsurgical in cause except when comanaged with the treating physician and surgeon, associated with conditions optometrists are authorized to treat.(G) Hypotrichosis and blepharitis.(H) Pursuant to subdivision (e), glaucoma in patients over 18 years of age, as described in subdivision (j). (k).(2) For purposes of this section, treat means the use of therapeutic pharmaceutical agents, as described in subdivision (c), and the procedures described in subdivision (d).(c) In diagnosing and treating the conditions listed in subdivision (b), an optometrist certified to use therapeutic pharmaceutical agents pursuant to Section 3041.3 may use or prescribe, including for rational off-label purposes, all of the following therapeutic pharmaceutical agents:(1) Topical pharmaceutical agents for the examination of the human eye or eyes for any disease or pathological condition, including, but not limited to, topical miotics.(2) Topical lubricants.(3) Antiallergy agents. In using topical steroid medication for the treatment of ocular allergies, an optometrist shall consult with an ophthalmologist if the patients condition worsens 21 days after diagnosis.(4) Topical and oral anti-inflammatories.(5) Topical antibiotic agents.(6) Topical hyperosmotics.(7) Topical and oral antiglaucoma agents pursuant to the certification process defined in subdivision (e).(8) Nonprescription medications used for the rational treatment of an ocular disorder.(9) Oral antihistamines.(10) Prescription oral nonsteroidal anti-inflammatory agents.(11) Oral antibiotics for medical treatment of ocular disease.(12) Topical and oral antiviral medication for the medical treatment of herpes simplex viral keratitis, herpes simplex viral conjunctivitis, periocular herpes simplex viral dermatitis, varicella zoster viral keratitis, varicella zoster viral conjunctivitis, and periocular varicella zoster viral dermatitis.(13) Oral analgesics that are not controlled substances.(14) Codeine with compounds, hydrocodone with compounds, and tramadol as listed in the California Uniform Controlled Substances Act (Division 10 (commencing with Section 11000) of the Health and Safety Code) and the United States Uniform Controlled Substances Act (21 U.S.C. Sec. 801 et seq.). The use of these agents shall be limited to three days, with a referral to an ophthalmologist if the pain persists.(15) Additional therapeutic pharmaceutical agents pursuant to subdivision (f).(d) An optometrist who is certified to use therapeutic pharmaceutical agents pursuant to Section 3041.3 may also perform all of the following procedures:(1) Corneal scraping with cultures.(2) Debridement of corneal epithelia.(3) Mechanical epilation.(4) Collection of blood by skin puncture or venipuncture for testing patients suspected of having diabetes.(5) Suture removal, with prior consultation with the treating physician and surgeon.(6) Treatment or removal of sebaceous cysts by expression.(7) Administration of oral fluorescein to patients suspected as having diabetic retinopathy.(8) Use of an auto-injector to counter anaphylaxis.(9) Ordering of smears, cultures, sensitivities, complete blood count, mycobacterial culture, acid fast stain, urinalysis, tear fluid analysis, and X-rays necessary for the diagnosis of conditions or diseases of the eye or adnexa. An optometrist may order other types of images subject to prior consultation with an ophthalmologist or appropriate physician and surgeon.(10) A clinical laboratory test or examination classified as waived under the federal Clinical Laboratory Improvement Amendments of 1988 (CLIA) (42 U.S.C. Sec. 263a; Public Law 100-578) and designated as waived in paragraph (9) necessary for the diagnosis of conditions and diseases of the eye or adnexa, or if otherwise specifically authorized by this chapter.(11) Punctal occlusion by plugs, excluding laser, diathermy, cryotherapy, or other means constituting surgery as defined in this chapter.(12) The use or prescription of diagnostic or therapeutic contact lenses, including lenses or devices that incorporate a medication or therapy the optometrist is certified to prescribe or provide.(13) Removal of foreign bodies from the cornea, eyelid, and conjunctiva with any appropriate instrument other than a scalpel. Corneal foreign bodies shall be nonperforating, be no deeper than the midstroma, and require no surgical repair upon removal.(14) For patients over 12 years of age, lacrimal irrigation and dilation, excluding probing of the nasal lacrimal tract. The board shall certify any optometrist who graduated from an accredited school of optometry before May 1, 2000, to perform this procedure after submitting proof of satisfactory completion of 10 procedures under the supervision of an ophthalmologist as confirmed by the ophthalmologist. Any optometrist who graduated from an accredited school of optometry on or after May 1, 2000, shall be exempt from the certification requirement contained in this paragraph.(15) Intravenous injection for the purpose of performing ocular angiography at the direction of an ophthalmologist as part of an active treatment plan in a setting where a physician and surgeon is immediately available.(16) Skin testing to diagnose ocular allergies, limited to the superficial layer of the skin.(17) Use of any noninvasive medical device or technology authorized pursuant to subdivision (f).(e) An optometrist certified pursuant to Section 3041.3 shall be certified for the treatment of glaucoma, as described in subdivision (j), (k), in patients over 18 years of age after the optometrist meets the following applicable requirements:(1) For licensees who graduated from an accredited school of optometry on or after May 1, 2008, submission of proof of graduation from that institution.(2) For licensees who were certified to treat glaucoma under this section prior to before January 1, 2009, submission of proof of completion of that certification program.(3) For licensees who completed a didactic course of not less than 24 hours in the diagnosis, pharmacological, and other treatment and management of glaucoma, submission of proof of satisfactory completion of the case management requirements for certification established by the board.(4) For licensees who graduated from an accredited school of optometry on or before May 1, 2008, and who are not described in paragraph (2) or (3), submission of proof of satisfactory completion of the requirements for certification established by the board under Chapter 352 of the Statutes of 2008.(f) (1) Any topical or oral therapeutic pharmaceutical agent, which is not a controlled substance, or noninvasive medical device or technology that is not expressly authorized for use or prescription by an optometrist certified to use therapeutic pharmaceutical agents pursuant to Section 3041.3 shall be deemed to be authorized if it has received a United States Food and Drug Administration approved indication for the diagnosis or treatment of a condition authorized by this chapter. A licensee shall successfully complete any clinical training imposed by a related manufacturer prior to before using any of those therapeutic pharmaceutical agents or noninvasive medical devices or technologies.(2) Any other topical or oral therapeutic pharmaceutical agent, which is not a controlled substance, or noninvasive medical device or technology that is not expressly authorized for use or prescription by an optometrist certified to use therapeutic pharmaceutical agents pursuant to Section 3041.3 and does not meet the requirements in paragraph (1) shall be deemed authorized if approved by the board through regulation for the rational treatment of a condition authorized by this chapter. Any regulation under this paragraph shall require a licensee to successfully complete an appropriate amount of clinical training to qualify to use each topical or oral therapeutic pharmaceutical agent or noninvasive medical device or technology approved by the board pursuant to this paragraph.(3) This subdivision shall not be construed to authorize any of the following:(A) Any therapeutic pharmaceutical agent, medical device, or technology involving cutting, altering, or otherwise infiltrating human tissue by any means.(B) A clinical laboratory test or imaging study not authorized by paragraphs (1) to (16), inclusive, of subdivision (d).(C) Treatment of any disease or condition that could not be treated by an optometrist before January 1, 2018.(g) (1) An optometrist certified pursuant to Section 3014.3 3041.3 shall be certified for the administration of immunizations after the optometrist meets all of the following requirements:(A) Completes an immunization training program endorsed by the federal Centers for Disease Control and Prevention (CDC) that, at a minimum, includes hands-on injection technique, clinical evaluation of indications and contradications of vaccines, and the recognition and treatment of emergency reactions to vaccines, and maintains that training.(B) Is certified in basic life support.(C) Complies with all state and federal recordkeeping and reporting requirements, including providing documentation to the patients primary care provided and entering information in the appropriate immunization registry designated by the immunization branch of the State Department of Public Health.(D) Applies for an immunization certificate on a board-approved form.(2) For the purposes of this section, immunization means the administration of immunizations for influenza, herpes zoster virus, and pneumococcus in compliance with individual Advisory Committee on Immunization Practices (ACIP) vaccine recommendations published by the CDC for persons 18 years of age or older.(h) Other than for prescription ophthalmic devices described in subdivision (b) of Section 2541, any dispensing of a therapeutic pharmaceutical agent by an optometrist shall be without charge.(i) The practice of optometry does not include performing surgery. Surgery means any procedure in which human tissue is cut, altered, or otherwise infiltrated by mechanical or laser means. Surgery does not include those procedures specified in paragraphs (1) to (15), inclusive, of subdivision (d). This subdivision does not limit an optometrists authority to utilize diagnostic laser and ultrasound technology within his or her scope of practice.(j) An optometrist licensed under this chapter is subject to the provisions of Section 2290.5 for purposes of practicing telehealth.(k) For purposes of this chapter, glaucoma means either of the following:(1) All primary open-angle glaucoma.(2) Exfoliation and pigmentary glaucoma.(3) (A) Steroid induced glaucoma.(B) If an optometrist treats a patient for steroid induced glaucoma the optometrist shall promptly notify the prescriber of the steroid medication if the prescriber did not refer the patient to the optometrist for treatment.(l) For purposes of this chapter, adnexa means ocular adnexa.(m) In an emergency, an optometrist shall stabilize, if possible, and immediately refer any patient who has an acute attack of angle closure to an ophthalmologist. | |
| 63 | 49 | ||
| 64 | - | ||
| 50 | + | 3041. (a) The practice of optometry includes the prevention and diagnosis of disorders and dysfunctions of the visual system, and the treatment and management of certain disorders and dysfunctions of the visual system, as well as the provision of habilitative or rehabilitative optometric services, and is the doing of any or all of the following:(1) The examination of the human eye or eyes, or its or their appendages, and the analysis of the human vision system, either subjectively or objectively.(2) The determination of the powers or range of human vision and the accommodative and refractive states of the human eye or eyes, including the scope of its or their functions and general condition.(3) The prescribing or directing the use of, or using, any optical device in connection with ocular exercises, visual training, vision training, or orthoptics.(4) The prescribing of contact and spectacle lenses for, or the fitting or adaptation of contact and spectacle lenses to, the human eye, including lenses that may be classified as drugs or devices by any law of the United States or of this state.(5) The use of topical pharmaceutical agents for the purpose of the examination of the human eye or eyes for any disease or pathological condition.(b) (1) An optometrist who is certified to use therapeutic pharmaceutical agents, pursuant to Section 3041.3, may also diagnose and treat the human eye or eyes, or any of its or their appendages, for all of the following conditions:(A) Through medical treatment, infections of the anterior segment and adnexa, excluding the lacrimal gland, the lacrimal drainage system, and the sclera in patients under 12 years of age.(B) Ocular allergies of the anterior segment and adnexa.(C) Ocular inflammation, nonsurgical in cause except when comanaged with the treating physician and surgeon, limited to inflammation resulting from traumatic iritis, peripheral corneal inflammatory keratitis, episcleritis, and unilateral nonrecurrent nongranulomatous idiopathic iritis in patients over 18 years of age.(D) Traumatic or recurrent conjunctival or corneal abrasions and erosions.(E) Nonmalignant ocular surface disease and dry eye disease.(F) Ocular pain, nonsurgical in cause except when comanaged with the treating physician and surgeon, associated with conditions optometrists are authorized to treat.(G) Hypotrichosis and blepharitis.(H) Pursuant to subdivision (e), glaucoma in patients over 18 years of age, as described in subdivision (j). (k).(2) For purposes of this section, treat means the use of therapeutic pharmaceutical agents, as described in subdivision (c), and the procedures described in subdivision (d).(c) In diagnosing and treating the conditions listed in subdivision (b), an optometrist certified to use therapeutic pharmaceutical agents pursuant to Section 3041.3 may use or prescribe, including for rational off-label purposes, all of the following therapeutic pharmaceutical agents:(1) Topical pharmaceutical agents for the examination of the human eye or eyes for any disease or pathological condition, including, but not limited to, topical miotics.(2) Topical lubricants.(3) Antiallergy agents. In using topical steroid medication for the treatment of ocular allergies, an optometrist shall consult with an ophthalmologist if the patients condition worsens 21 days after diagnosis.(4) Topical and oral anti-inflammatories.(5) Topical antibiotic agents.(6) Topical hyperosmotics.(7) Topical and oral antiglaucoma agents pursuant to the certification process defined in subdivision (e).(8) Nonprescription medications used for the rational treatment of an ocular disorder.(9) Oral antihistamines.(10) Prescription oral nonsteroidal anti-inflammatory agents.(11) Oral antibiotics for medical treatment of ocular disease.(12) Topical and oral antiviral medication for the medical treatment of herpes simplex viral keratitis, herpes simplex viral conjunctivitis, periocular herpes simplex viral dermatitis, varicella zoster viral keratitis, varicella zoster viral conjunctivitis, and periocular varicella zoster viral dermatitis.(13) Oral analgesics that are not controlled substances.(14) Codeine with compounds, hydrocodone with compounds, and tramadol as listed in the California Uniform Controlled Substances Act (Division 10 (commencing with Section 11000) of the Health and Safety Code) and the United States Uniform Controlled Substances Act (21 U.S.C. Sec. 801 et seq.). The use of these agents shall be limited to three days, with a referral to an ophthalmologist if the pain persists.(15) Additional therapeutic pharmaceutical agents pursuant to subdivision (f).(d) An optometrist who is certified to use therapeutic pharmaceutical agents pursuant to Section 3041.3 may also perform all of the following procedures:(1) Corneal scraping with cultures.(2) Debridement of corneal epithelia.(3) Mechanical epilation.(4) Collection of blood by skin puncture or venipuncture for testing patients suspected of having diabetes.(5) Suture removal, with prior consultation with the treating physician and surgeon.(6) Treatment or removal of sebaceous cysts by expression.(7) Administration of oral fluorescein to patients suspected as having diabetic retinopathy.(8) Use of an auto-injector to counter anaphylaxis.(9) Ordering of smears, cultures, sensitivities, complete blood count, mycobacterial culture, acid fast stain, urinalysis, tear fluid analysis, and X-rays necessary for the diagnosis of conditions or diseases of the eye or adnexa. An optometrist may order other types of images subject to prior consultation with an ophthalmologist or appropriate physician and surgeon.(10) A clinical laboratory test or examination classified as waived under the federal Clinical Laboratory Improvement Amendments of 1988 (CLIA) (42 U.S.C. Sec. 263a; Public Law 100-578) and designated as waived in paragraph (9) necessary for the diagnosis of conditions and diseases of the eye or adnexa, or if otherwise specifically authorized by this chapter.(11) Punctal occlusion by plugs, excluding laser, diathermy, cryotherapy, or other means constituting surgery as defined in this chapter.(12) The use or prescription of diagnostic or therapeutic contact lenses, including lenses or devices that incorporate a medication or therapy the optometrist is certified to prescribe or provide.(13) Removal of foreign bodies from the cornea, eyelid, and conjunctiva with any appropriate instrument other than a scalpel. Corneal foreign bodies shall be nonperforating, be no deeper than the midstroma, and require no surgical repair upon removal.(14) For patients over 12 years of age, lacrimal irrigation and dilation, excluding probing of the nasal lacrimal tract. The board shall certify any optometrist who graduated from an accredited school of optometry before May 1, 2000, to perform this procedure after submitting proof of satisfactory completion of 10 procedures under the supervision of an ophthalmologist as confirmed by the ophthalmologist. Any optometrist who graduated from an accredited school of optometry on or after May 1, 2000, shall be exempt from the certification requirement contained in this paragraph.(15) Intravenous injection for the purpose of performing ocular angiography at the direction of an ophthalmologist as part of an active treatment plan in a setting where a physician and surgeon is immediately available.(16) Skin testing to diagnose ocular allergies, limited to the superficial layer of the skin.(17) Use of any noninvasive medical device or technology authorized pursuant to subdivision (f).(e) An optometrist certified pursuant to Section 3041.3 shall be certified for the treatment of glaucoma, as described in subdivision (j), (k), in patients over 18 years of age after the optometrist meets the following applicable requirements:(1) For licensees who graduated from an accredited school of optometry on or after May 1, 2008, submission of proof of graduation from that institution.(2) For licensees who were certified to treat glaucoma under this section prior to before January 1, 2009, submission of proof of completion of that certification program.(3) For licensees who completed a didactic course of not less than 24 hours in the diagnosis, pharmacological, and other treatment and management of glaucoma, submission of proof of satisfactory completion of the case management requirements for certification established by the board.(4) For licensees who graduated from an accredited school of optometry on or before May 1, 2008, and who are not described in paragraph (2) or (3), submission of proof of satisfactory completion of the requirements for certification established by the board under Chapter 352 of the Statutes of 2008.(f) (1) Any topical or oral therapeutic pharmaceutical agent, which is not a controlled substance, or noninvasive medical device or technology that is not expressly authorized for use or prescription by an optometrist certified to use therapeutic pharmaceutical agents pursuant to Section 3041.3 shall be deemed to be authorized if it has received a United States Food and Drug Administration approved indication for the diagnosis or treatment of a condition authorized by this chapter. A licensee shall successfully complete any clinical training imposed by a related manufacturer prior to before using any of those therapeutic pharmaceutical agents or noninvasive medical devices or technologies.(2) Any other topical or oral therapeutic pharmaceutical agent, which is not a controlled substance, or noninvasive medical device or technology that is not expressly authorized for use or prescription by an optometrist certified to use therapeutic pharmaceutical agents pursuant to Section 3041.3 and does not meet the requirements in paragraph (1) shall be deemed authorized if approved by the board through regulation for the rational treatment of a condition authorized by this chapter. Any regulation under this paragraph shall require a licensee to successfully complete an appropriate amount of clinical training to qualify to use each topical or oral therapeutic pharmaceutical agent or noninvasive medical device or technology approved by the board pursuant to this paragraph.(3) This subdivision shall not be construed to authorize any of the following:(A) Any therapeutic pharmaceutical agent, medical device, or technology involving cutting, altering, or otherwise infiltrating human tissue by any means.(B) A clinical laboratory test or imaging study not authorized by paragraphs (1) to (16), inclusive, of subdivision (d).(C) Treatment of any disease or condition that could not be treated by an optometrist before January 1, 2018.(g) (1) An optometrist certified pursuant to Section 3014.3 3041.3 shall be certified for the administration of immunizations after the optometrist meets all of the following requirements:(A) Completes an immunization training program endorsed by the federal Centers for Disease Control and Prevention (CDC) that, at a minimum, includes hands-on injection technique, clinical evaluation of indications and contradications of vaccines, and the recognition and treatment of emergency reactions to vaccines, and maintains that training.(B) Is certified in basic life support.(C) Complies with all state and federal recordkeeping and reporting requirements, including providing documentation to the patients primary care provided and entering information in the appropriate immunization registry designated by the immunization branch of the State Department of Public Health.(D) Applies for an immunization certificate on a board-approved form.(2) For the purposes of this section, immunization means the administration of immunizations for influenza, herpes zoster virus, and pneumococcus in compliance with individual Advisory Committee on Immunization Practices (ACIP) vaccine recommendations published by the CDC for persons 18 years of age or older.(h) Other than for prescription ophthalmic devices described in subdivision (b) of Section 2541, any dispensing of a therapeutic pharmaceutical agent by an optometrist shall be without charge.(i) The practice of optometry does not include performing surgery. Surgery means any procedure in which human tissue is cut, altered, or otherwise infiltrated by mechanical or laser means. Surgery does not include those procedures specified in paragraphs (1) to (15), inclusive, of subdivision (d). This subdivision does not limit an optometrists authority to utilize diagnostic laser and ultrasound technology within his or her scope of practice.(j) An optometrist licensed under this chapter is subject to the provisions of Section 2290.5 for purposes of practicing telehealth.(k) For purposes of this chapter, glaucoma means either of the following:(1) All primary open-angle glaucoma.(2) Exfoliation and pigmentary glaucoma.(3) (A) Steroid induced glaucoma.(B) If an optometrist treats a patient for steroid induced glaucoma the optometrist shall promptly notify the prescriber of the steroid medication if the prescriber did not refer the patient to the optometrist for treatment.(l) For purposes of this chapter, adnexa means ocular adnexa.(m) In an emergency, an optometrist shall stabilize, if possible, and immediately refer any patient who has an acute attack of angle closure to an ophthalmologist. | |
| 65 | 51 | ||
| 66 | - | ||
| 52 | + | 3041. (a) The practice of optometry includes the prevention and diagnosis of disorders and dysfunctions of the visual system, and the treatment and management of certain disorders and dysfunctions of the visual system, as well as the provision of habilitative or rehabilitative optometric services, and is the doing of any or all of the following:(1) The examination of the human eye or eyes, or its or their appendages, and the analysis of the human vision system, either subjectively or objectively.(2) The determination of the powers or range of human vision and the accommodative and refractive states of the human eye or eyes, including the scope of its or their functions and general condition.(3) The prescribing or directing the use of, or using, any optical device in connection with ocular exercises, visual training, vision training, or orthoptics.(4) The prescribing of contact and spectacle lenses for, or the fitting or adaptation of contact and spectacle lenses to, the human eye, including lenses that may be classified as drugs or devices by any law of the United States or of this state.(5) The use of topical pharmaceutical agents for the purpose of the examination of the human eye or eyes for any disease or pathological condition.(b) (1) An optometrist who is certified to use therapeutic pharmaceutical agents, pursuant to Section 3041.3, may also diagnose and treat the human eye or eyes, or any of its or their appendages, for all of the following conditions:(A) Through medical treatment, infections of the anterior segment and adnexa, excluding the lacrimal gland, the lacrimal drainage system, and the sclera in patients under 12 years of age.(B) Ocular allergies of the anterior segment and adnexa.(C) Ocular inflammation, nonsurgical in cause except when comanaged with the treating physician and surgeon, limited to inflammation resulting from traumatic iritis, peripheral corneal inflammatory keratitis, episcleritis, and unilateral nonrecurrent nongranulomatous idiopathic iritis in patients over 18 years of age.(D) Traumatic or recurrent conjunctival or corneal abrasions and erosions.(E) Nonmalignant ocular surface disease and dry eye disease.(F) Ocular pain, nonsurgical in cause except when comanaged with the treating physician and surgeon, associated with conditions optometrists are authorized to treat.(G) Hypotrichosis and blepharitis.(H) Pursuant to subdivision (e), glaucoma in patients over 18 years of age, as described in subdivision (j). (k).(2) For purposes of this section, treat means the use of therapeutic pharmaceutical agents, as described in subdivision (c), and the procedures described in subdivision (d).(c) In diagnosing and treating the conditions listed in subdivision (b), an optometrist certified to use therapeutic pharmaceutical agents pursuant to Section 3041.3 may use or prescribe, including for rational off-label purposes, all of the following therapeutic pharmaceutical agents:(1) Topical pharmaceutical agents for the examination of the human eye or eyes for any disease or pathological condition, including, but not limited to, topical miotics.(2) Topical lubricants.(3) Antiallergy agents. In using topical steroid medication for the treatment of ocular allergies, an optometrist shall consult with an ophthalmologist if the patients condition worsens 21 days after diagnosis.(4) Topical and oral anti-inflammatories.(5) Topical antibiotic agents.(6) Topical hyperosmotics.(7) Topical and oral antiglaucoma agents pursuant to the certification process defined in subdivision (e).(8) Nonprescription medications used for the rational treatment of an ocular disorder.(9) Oral antihistamines.(10) Prescription oral nonsteroidal anti-inflammatory agents.(11) Oral antibiotics for medical treatment of ocular disease.(12) Topical and oral antiviral medication for the medical treatment of herpes simplex viral keratitis, herpes simplex viral conjunctivitis, periocular herpes simplex viral dermatitis, varicella zoster viral keratitis, varicella zoster viral conjunctivitis, and periocular varicella zoster viral dermatitis.(13) Oral analgesics that are not controlled substances.(14) Codeine with compounds, hydrocodone with compounds, and tramadol as listed in the California Uniform Controlled Substances Act (Division 10 (commencing with Section 11000) of the Health and Safety Code) and the United States Uniform Controlled Substances Act (21 U.S.C. Sec. 801 et seq.). The use of these agents shall be limited to three days, with a referral to an ophthalmologist if the pain persists.(15) Additional therapeutic pharmaceutical agents pursuant to subdivision (f).(d) An optometrist who is certified to use therapeutic pharmaceutical agents pursuant to Section 3041.3 may also perform all of the following procedures:(1) Corneal scraping with cultures.(2) Debridement of corneal epithelia.(3) Mechanical epilation.(4) Collection of blood by skin puncture or venipuncture for testing patients suspected of having diabetes.(5) Suture removal, with prior consultation with the treating physician and surgeon.(6) Treatment or removal of sebaceous cysts by expression.(7) Administration of oral fluorescein to patients suspected as having diabetic retinopathy.(8) Use of an auto-injector to counter anaphylaxis.(9) Ordering of smears, cultures, sensitivities, complete blood count, mycobacterial culture, acid fast stain, urinalysis, tear fluid analysis, and X-rays necessary for the diagnosis of conditions or diseases of the eye or adnexa. An optometrist may order other types of images subject to prior consultation with an ophthalmologist or appropriate physician and surgeon.(10) A clinical laboratory test or examination classified as waived under the federal Clinical Laboratory Improvement Amendments of 1988 (CLIA) (42 U.S.C. Sec. 263a; Public Law 100-578) and designated as waived in paragraph (9) necessary for the diagnosis of conditions and diseases of the eye or adnexa, or if otherwise specifically authorized by this chapter.(11) Punctal occlusion by plugs, excluding laser, diathermy, cryotherapy, or other means constituting surgery as defined in this chapter.(12) The use or prescription of diagnostic or therapeutic contact lenses, including lenses or devices that incorporate a medication or therapy the optometrist is certified to prescribe or provide.(13) Removal of foreign bodies from the cornea, eyelid, and conjunctiva with any appropriate instrument other than a scalpel. Corneal foreign bodies shall be nonperforating, be no deeper than the midstroma, and require no surgical repair upon removal.(14) For patients over 12 years of age, lacrimal irrigation and dilation, excluding probing of the nasal lacrimal tract. The board shall certify any optometrist who graduated from an accredited school of optometry before May 1, 2000, to perform this procedure after submitting proof of satisfactory completion of 10 procedures under the supervision of an ophthalmologist as confirmed by the ophthalmologist. Any optometrist who graduated from an accredited school of optometry on or after May 1, 2000, shall be exempt from the certification requirement contained in this paragraph.(15) Intravenous injection for the purpose of performing ocular angiography at the direction of an ophthalmologist as part of an active treatment plan in a setting where a physician and surgeon is immediately available.(16) Skin testing to diagnose ocular allergies, limited to the superficial layer of the skin.(17) Use of any noninvasive medical device or technology authorized pursuant to subdivision (f).(e) An optometrist certified pursuant to Section 3041.3 shall be certified for the treatment of glaucoma, as described in subdivision (j), (k), in patients over 18 years of age after the optometrist meets the following applicable requirements:(1) For licensees who graduated from an accredited school of optometry on or after May 1, 2008, submission of proof of graduation from that institution.(2) For licensees who were certified to treat glaucoma under this section prior to before January 1, 2009, submission of proof of completion of that certification program.(3) For licensees who completed a didactic course of not less than 24 hours in the diagnosis, pharmacological, and other treatment and management of glaucoma, submission of proof of satisfactory completion of the case management requirements for certification established by the board.(4) For licensees who graduated from an accredited school of optometry on or before May 1, 2008, and who are not described in paragraph (2) or (3), submission of proof of satisfactory completion of the requirements for certification established by the board under Chapter 352 of the Statutes of 2008.(f) (1) Any topical or oral therapeutic pharmaceutical agent, which is not a controlled substance, or noninvasive medical device or technology that is not expressly authorized for use or prescription by an optometrist certified to use therapeutic pharmaceutical agents pursuant to Section 3041.3 shall be deemed to be authorized if it has received a United States Food and Drug Administration approved indication for the diagnosis or treatment of a condition authorized by this chapter. A licensee shall successfully complete any clinical training imposed by a related manufacturer prior to before using any of those therapeutic pharmaceutical agents or noninvasive medical devices or technologies.(2) Any other topical or oral therapeutic pharmaceutical agent, which is not a controlled substance, or noninvasive medical device or technology that is not expressly authorized for use or prescription by an optometrist certified to use therapeutic pharmaceutical agents pursuant to Section 3041.3 and does not meet the requirements in paragraph (1) shall be deemed authorized if approved by the board through regulation for the rational treatment of a condition authorized by this chapter. Any regulation under this paragraph shall require a licensee to successfully complete an appropriate amount of clinical training to qualify to use each topical or oral therapeutic pharmaceutical agent or noninvasive medical device or technology approved by the board pursuant to this paragraph.(3) This subdivision shall not be construed to authorize any of the following:(A) Any therapeutic pharmaceutical agent, medical device, or technology involving cutting, altering, or otherwise infiltrating human tissue by any means.(B) A clinical laboratory test or imaging study not authorized by paragraphs (1) to (16), inclusive, of subdivision (d).(C) Treatment of any disease or condition that could not be treated by an optometrist before January 1, 2018.(g) (1) An optometrist certified pursuant to Section 3014.3 3041.3 shall be certified for the administration of immunizations after the optometrist meets all of the following requirements:(A) Completes an immunization training program endorsed by the federal Centers for Disease Control and Prevention (CDC) that, at a minimum, includes hands-on injection technique, clinical evaluation of indications and contradications of vaccines, and the recognition and treatment of emergency reactions to vaccines, and maintains that training.(B) Is certified in basic life support.(C) Complies with all state and federal recordkeeping and reporting requirements, including providing documentation to the patients primary care provided and entering information in the appropriate immunization registry designated by the immunization branch of the State Department of Public Health.(D) Applies for an immunization certificate on a board-approved form.(2) For the purposes of this section, immunization means the administration of immunizations for influenza, herpes zoster virus, and pneumococcus in compliance with individual Advisory Committee on Immunization Practices (ACIP) vaccine recommendations published by the CDC for persons 18 years of age or older.(h) Other than for prescription ophthalmic devices described in subdivision (b) of Section 2541, any dispensing of a therapeutic pharmaceutical agent by an optometrist shall be without charge.(i) The practice of optometry does not include performing surgery. Surgery means any procedure in which human tissue is cut, altered, or otherwise infiltrated by mechanical or laser means. Surgery does not include those procedures specified in paragraphs (1) to (15), inclusive, of subdivision (d). This subdivision does not limit an optometrists authority to utilize diagnostic laser and ultrasound technology within his or her scope of practice.(j) An optometrist licensed under this chapter is subject to the provisions of Section 2290.5 for purposes of practicing telehealth.(k) For purposes of this chapter, glaucoma means either of the following:(1) All primary open-angle glaucoma.(2) Exfoliation and pigmentary glaucoma.(3) (A) Steroid induced glaucoma.(B) If an optometrist treats a patient for steroid induced glaucoma the optometrist shall promptly notify the prescriber of the steroid medication if the prescriber did not refer the patient to the optometrist for treatment.(l) For purposes of this chapter, adnexa means ocular adnexa.(m) In an emergency, an optometrist shall stabilize, if possible, and immediately refer any patient who has an acute attack of angle closure to an ophthalmologist. | |
| 67 | 53 | ||
| 68 | 54 | ||
| 69 | 55 | ||
| 70 | - | 655. (a) For the purposes of this section, the following terms have the following meanings: | |
| 71 | - | ||
| 72 | - | (1) Health plan means a health care service plan licensed pursuant to the Knox-Keene Health Care Service Plan Act of 1975 (Chapter 2.2 (commencing with Section 1340) of Division 2 of the Health and Safety Code). | |
| 73 | - | ||
| 74 | - | (2) Optical company means a person or entity that is engaged in the manufacture, sale, or distribution to physicians and surgeons, optometrists, health plans, or dispensing opticians of lenses, frames, optical supplies, or optometric appliances or devices or kindred products. | |
| 75 | - | ||
| 76 | - | (3) Optometrist means a person licensed pursuant to Chapter 7 (commencing with Section 3000) or an optometric corporation, as described in Section 3160. | |
| 77 | - | ||
| 78 | - | (4) Registered dispensing Dispensing optician means a person licensed an individual, corporation, or firm engaged in the business of filling prescriptions of physicians and surgeons licensed by the Medical Board of California or optometrists licensed by the State Board of Optometry for prescription lenses and kindred products, and, as incidental to the filling of those prescriptions, doing any or all of the following acts, either singly or in combination with others, taking facial measurements, fitting and adjusting those lenses, and fitting and adjusting spectacle frames, regardless of whether the individual, corporation, or firm is registered as a registered dispensing optician pursuant to Chapter 5.5 (commencing with Section 2550). | |
| 79 | - | ||
| 80 | - | (5) Therapeutic ophthalmic product means lenses or other products that provide direct treatment of eye disease or visual rehabilitation for diseased eyes. | |
| 81 | - | ||
| 82 | - | (b) No optometrist may have any membership, proprietary interest, coownership, or any profit-sharing arrangement, either by stock ownership, interlocking directors, trusteeship, mortgage, or trust deed, with any registered dispensing optician or any optical company, except as otherwise permitted under this section. | |
| 83 | - | ||
| 84 | - | (c) (1) A registered dispensing optician or an optical company may operate, own, or have an ownership interest in a health plan so long as the health plan does not directly employ optometrists to provide optometric services directly to enrollees of the health plan, and may directly or indirectly provide products and services to the health plan or its contracted providers or enrollees or to other optometrists. For purposes of this section, an optometrist may be employed by a health plan as a clinical director for the health plan pursuant to Section 1367.01 of the Health and Safety Code or to perform services related to utilization management or quality assurance or other similar related services that do not require the optometrist to directly provide health care services to enrollees. In addition, an optometrist serving as a clinical director may not employ optometrists to provide health care services to enrollees of the health plan for which the optometrist is serving as clinical director. For the purposes of this section, the health plans utilization management and quality assurance programs that are consistent with the Knox-Keene Health Care Service Plan Act of 1975 (Chapter 2.2 (commencing with Section 1340) of Division 2 of the Health and Safety Code) do not constitute providing health care services to enrollees. | |
| 85 | - | ||
| 86 | - | (2) The registered dispensing optician or optical company shall not interfere with the professional judgment of the optometrist. | |
| 87 | - | ||
| 88 | - | (3) The Department of Managed Health Care shall forward to the State Board of Optometry any complaints received from consumers that allege that an optometrist violated the Optometry Practice Act (Chapter 7 (commencing with Section 3000)). The Department of Managed Health Care and the State Board of Optometry shall enter into an Inter-Agency Agreement regarding the sharing of information related to the services provided by an optometrist that may be in violation of the Optometry Practice Act that the Department of Managed Health Care encounters in the course of the administration of the Knox-Keene Health Care Service Plan Act of 1975 (Chapter 2.2 (commencing with Section 1340) of Division 2 of the Health and Safety Code). | |
| 89 | - | ||
| 90 | - | (d) An optometrist, a registered dispensing optician, an optical company, or a health plan may execute a lease or other written agreement giving rise to a direct or indirect landlord-tenant relationship with an optometrist, if all of the following conditions are contained in a written agreement establishing the landlord-tenant relationship: | |
| 91 | - | ||
| 92 | - | (1) (A) The practice shall be owned by the optometrist and in every phase be under the optometrists exclusive control, including the selection and supervision of optometric staff, the scheduling of patients, the amount of time the optometrist spends with patients, fees charged for optometric products and services, the examination procedures and treatment provided to patients and the optometrists contracting with managed care organizations. | |
| 93 | - | ||
| 94 | - | (B) Subparagraph (A) shall not preclude a lease from including commercially reasonable terms that: (i) require the provision of optometric services at the leased space during certain days and hours, (ii) restrict the leased space from being used for the sale or offer for sale of spectacles, frames, lenses, contact lenses, or other ophthalmic products, except that the optometrist shall be permitted to sell therapeutic ophthalmic products if the registered dispensing optician, health plan, or optical company located on or adjacent to the optometrists leased space does not offer any substantially similar therapeutic ophthalmic products for sale, (iii) require the optometrist to contract with a health plan network, health plan, or health insurer, or (iv) permit the landlord to directly or indirectly provide furnishings and equipment in the leased space. | |
| 95 | - | ||
| 96 | - | (2) The optometrists records shall be the sole property of the optometrist. Only the optometrist and those persons with written authorization from the optometrist shall have access to the patient records and the examination room, except as otherwise provided by law. | |
| 97 | - | ||
| 98 | - | (3) The optometrists leased space shall be definite and distinct from space occupied by other occupants of the premises, have a sign designating that the leased space is occupied by an independent optometrist or optometrists and be accessible to the optometrist after hours or in the case of an emergency, subject to the facilitys general accessibility. This paragraph shall not require a separate entrance to the optometrists leased space. | |
| 99 | - | ||
| 100 | - | (4) All signs and displays shall be separate and distinct from that of the other occupants and shall have the optometrists name and the word optometrist prominently displayed in connection therewith. This paragraph shall not prohibit the optometrist from advertising the optometrists practice location with reference to other occupants or prohibit the optometrist or registered dispensing optician from advertising their participation in any health plans network or the health plans products in which the optometrist or registered dispensing optician participates. | |
| 101 | - | ||
| 102 | - | (5) There shall be no signs displayed on any part of the premises or in any advertising indicating that the optometrist is employed or controlled by the registered dispensing optician, health plan plan, or optical company. | |
| 103 | - | ||
| 104 | - | (6) Except for a statement that an independent doctor of optometry is located in the leased space, in-store pricing signs and as otherwise permitted by this subdivision, the registered dispensing optician or optical company shall not link its advertising with the optometrists name, practice, or fees. | |
| 105 | - | ||
| 106 | - | (7) Notwithstanding paragraphs (4) and (6), this subdivision shall not preclude a health plan from advertising its health plan products and associated premium costs and any copayments, coinsurance, deductibles, or other forms of cost sharing, or the names and locations of the health plans providers, including any optometrists or registered dispensing opticians that provide professional services, in compliance with the Knox-Keene Health Care Service Plan Act of 1975 (Chapter 2.2 (commencing with Section 1340) of Division 2 of the Health and Safety Code). | |
| 107 | - | ||
| 108 | - | (8) A health plan that advertises its products and services in accordance with paragraph (7) shall not advertise the optometrists fees for products and services that are not included in the health plans contract with the optometrist. | |
| 109 | - | ||
| 110 | - | (9) The optometrist shall not be precluded from collecting fees for services that are not included in a health plans products and services, subject to any patient disclosure requirements contained in the health plans provider agreement with the optometrist or that are not otherwise prohibited by the Knox-Keene Health Care Service Plan Act of 1975 (Chapter 2.2 (commencing with Section 1340) of Division 2 of the Health and Safety Code). | |
| 111 | - | ||
| 112 | - | (10) The term of the lease shall be no less than one year and shall not require the optometrist to contract exclusively with a health plan. The optometrist may terminate the lease according to the terms of the lease. The landlord may terminate the lease for the following reasons: | |
| 113 | - | ||
| 114 | - | (A) The optometrists failure to maintain a license to practice optometry or the imposition of restrictions, suspension or revocation of the optometrists license or if the optometrist or the optometrists employee is or becomes ineligible to participate in state or federal government-funded programs. | |
| 115 | - | ||
| 116 | - | (B) Termination of any underlying lease where the optometrist has subleased space, or the optometrists failure to comply with the underlying lease provisions that are made applicable to the optometrist. | |
| 117 | - | ||
| 118 | - | (C) If the health plan is the landlord, the termination of the provider agreement between the health plan and the optometrist, in accordance with the Knox-Keene Health Care Service Plan Act of 1975 (Chapter 2.2 (commencing with Section 1340) of Division 2 of the Health and Safety Code). | |
| 119 | - | ||
| 120 | - | (D) Other reasons pursuant to the terms of the lease or permitted under the Civil Code. | |
| 121 | - | ||
| 122 | - | (11) The landlord shall act in good faith in terminating the lease and in no case shall the landlord terminate the lease for reasons that constitute interference with the practice of optometry. | |
| 123 | - | ||
| 124 | - | (12) Lease or rent terms and payments shall not be based on number of eye exams performed, prescriptions written, patient referrals or the sale or promotion of the products of a registered dispensing optician or an optical company. | |
| 125 | - | ||
| 126 | - | (13) The landlord shall not terminate the lease solely because of a report, complaint, or allegation filed by the optometrist against the landlord, a registered dispensing optician optician, or a health plan, to the State Board of Optometry or the Department of Managed Health Care or any law enforcement or regulatory agency. | |
| 127 | - | ||
| 128 | - | (14) The landlord shall provide the optometrist with written notice of the scheduled expiration date of a lease at least 60 days prior to the scheduled expiration date. This notice obligation shall not affect the ability of either party to terminate the lease pursuant to this section. The landlord may not interfere with an outgoing optometrists efforts to inform the optometrists patients, in accordance with customary practice and professional obligations, of the relocation of the optometrists practice. | |
| 129 | - | ||
| 130 | - | (15) The State Board of Optometry may inspect, upon request, an individual lease agreement pursuant to its investigational authority, and if such a request is made, the landlord or tenant, as applicable, shall promptly comply with the request. Failure or refusal to comply with the request for lease agreements within 30 days of receiving the request constitutes unprofessional conduct and is grounds for disciplinary action by the appropriate regulatory agency. This section shall not affect the Department of Managed Health Cares authority to inspect all books and records of a health plan pursuant to Section 1381 of the Health and Safety Code. | |
| 131 | - | ||
| 132 | - | Any financial information contained in the lease submitted to a regulatory entity, pursuant to this paragraph, shall be considered confidential trade secret information that is exempt from disclosure under the California Public Records Act (Chapter 3.5 (commencing with Section 6250) of Division 7 of Title 1 of the Government Code). | |
| 133 | - | ||
| 134 | - | (16) This subdivision shall not be applicable to the relationship between any optometrist employee and the employer medical group, or the relationship between a medical group exclusively contracted with a health plan regulated by the Department of Managed Health Care and that health plan. | |
| 135 | - | ||
| 136 | - | (e) No registered dispensing optician may have any membership, proprietary interest, coownership, or profit-sharing arrangement either by stock ownership, interlocking directors, trusteeship, mortgage, or trust deed, with an optometrist, except as permitted under this section. | |
| 137 | - | ||
| 138 | - | (f) Nothing in this section shall prohibit a person licensed under Chapter 5 (commencing with Section 2000) or its professional corporation from contracting with or employing optometrists, ophthalmologists, or optometric assistants and entering into a contract or landlord tenant relationship with a health plan, an optical company, or a registered dispensing optician, in accordance with Sections 650 and 654 of this code. | |
| 139 | - | ||
| 140 | - | (g) Any violation of this section constitutes a misdemeanor as to such person licensed under Chapter 7 (commencing with Section 3000) of this division and as to any and all persons, whether or not so licensed under this division, who participate with such licensed person in a violation of any provision of this section. | |
| 141 | - | ||
| 142 | - | (h) (1) Notwithstanding any other law and in addition to any action available to the State Board of Optometry, the State Board of Optometry may issue a citation containing an order of abatement, an order to pay an administrative fine, or both, to an optical company, an optometrist, or a registered dispensing optician for a violation of this section. The administrative fine shall not exceed fifty thousand dollars ($50,000) per investigation. In assessing the amount of the fine, the board shall give due consideration to all of the following: | |
| 143 | - | ||
| 144 | - | (A) The gravity of the violation. | |
| 145 | - | ||
| 146 | - | (B) The good faith of the cited person or entity. | |
| 147 | - | ||
| 148 | - | (C) The history of previous violations of the same or similar nature. | |
| 149 | - | ||
| 150 | - | (D) Evidence that the violation was or was not willful. | |
| 151 | - | ||
| 152 | - | (E) The extent to which the cited person or entity has cooperated with the boards investigation. | |
| 153 | - | ||
| 154 | - | (F) The extent to which the cited person or entity has mitigated or attempted to mitigate any damage or injury caused by the violation. | |
| 155 | - | ||
| 156 | - | (G) Any other factors as justice may require. | |
| 157 | - | ||
| 158 | - | (2) A citation or fine assessment issued pursuant to a citation shall inform the cited person or entity that if a hearing is desired to contest the finding of a violation, that hearing shall be requested by written notice to the board within 30 days of the date of issuance of the citation or assessment. If a hearing is not requested pursuant to this section, payment of any fine shall not constitute an admission of the violation charged. Hearings shall be held pursuant to Chapter 5 (commencing with Section 11500) of Part 1 of Division 3 of Title 2 of the Government Code. | |
| 159 | - | ||
| 160 | - | (3) The board shall adopt regulations to implement a system for the issuance of citations, administrative fines, and orders of abatement authorized by this section. The regulations shall include provisions for both of the following: | |
| 161 | - | ||
| 162 | - | (A) The issuance of a citation without an administrative fine. | |
| 163 | - | ||
| 164 | - | (B) The opportunity for a cited person or entity to have an informal conference with the executive officer of the board in addition to the hearing described in paragraph (2). | |
| 165 | - | ||
| 166 | - | (4) The failure of a licensee to pay a fine within 30 days of the date of assessment, unless the citation is being appealed, may result in disciplinary action being taken by the board. Where a citation is not contested and a fine is not paid, the full amount of the assessed fine shall be added to the fee for renewal of the license. A license shall not be renewed without payment of the renewal fee and fine. | |
| 167 | - | ||
| 168 | - | (5) Notwithstanding any other law, if a fine is paid to satisfy an assessment based on the finding of a violation, payment of the fine shall be represented as satisfactory resolution of the matter for purposes of public disclosure. | |
| 169 | - | ||
| 170 | - | (i) Administrative fines collected pursuant to this section shall be deposited in the Dispensing Opticians Fund. It is the intent of the Legislature that moneys collected as fines and deposited in the fund be used by the board primarily for enforcement purposes. | |
| 171 | - | ||
| 172 | - | (j) Nothing in this section shall be construed to authorize a dispensing optician to engage in business in this state without registering with the State Board of Optometry pursuant to Chapter 5.5 (commencing with Section 2550). | |
| 173 | - | ||
| 174 | - | SEC. 2. No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution. | |
| 175 | - | ||
| 176 | - | SEC. 2. No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution. | |
| 177 | - | ||
| 178 | - | SEC. 2. No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution. | |
| 179 | - | ||
| 180 | - | ### SEC. 2. | |
| 181 | - | ||
| 182 | - | ||
| 183 | - | ||
| 184 | - | ||
| 185 | - | ||
| 186 | - | (a)The practice of optometry includes the prevention and diagnosis of disorders and dysfunctions of the visual system, and the treatment and management of certain disorders and dysfunctions of the visual system, as well as the provision of habilitative or rehabilitative optometric services, and is the doing of any or all of the following: | |
| 187 | - | ||
| 188 | - | ||
| 56 | + | 3041. (a) The practice of optometry includes the prevention and diagnosis of disorders and dysfunctions of the visual system, and the treatment and management of certain disorders and dysfunctions of the visual system, as well as the provision of habilitative or rehabilitative optometric services, and is the doing of any or all of the following: | |
| 189 | 57 | ||
| 190 | 58 | (1) The examination of the human eye or eyes, or its or their appendages, and the analysis of the human vision system, either subjectively or objectively. | |
| 191 | 59 | ||
| 192 | - | ||
| 193 | - | ||
| 194 | 60 | (2) The determination of the powers or range of human vision and the accommodative and refractive states of the human eye or eyes, including the scope of its or their functions and general condition. | |
| 195 | - | ||
| 196 | - | ||
| 197 | 61 | ||
| 198 | 62 | (3) The prescribing or directing the use of, or using, any optical device in connection with ocular exercises, visual training, vision training, or orthoptics. | |
| 199 | 63 | ||
| 200 | - | ||
| 201 | - | ||
| 202 | 64 | (4) The prescribing of contact and spectacle lenses for, or the fitting or adaptation of contact and spectacle lenses to, the human eye, including lenses that may be classified as drugs or devices by any law of the United States or of this state. | |
| 203 | - | ||
| 204 | - | ||
| 205 | 65 | ||
| 206 | 66 | (5) The use of topical pharmaceutical agents for the purpose of the examination of the human eye or eyes for any disease or pathological condition. | |
| 207 | 67 | ||
| 208 | - | ||
| 209 | - | ||
| 210 | 68 | (b) (1) An optometrist who is certified to use therapeutic pharmaceutical agents, pursuant to Section 3041.3, may also diagnose and treat the human eye or eyes, or any of its or their appendages, for all of the following conditions: | |
| 211 | - | ||
| 212 | - | ||
| 213 | 69 | ||
| 214 | 70 | (A) Through medical treatment, infections of the anterior segment and adnexa, excluding the lacrimal gland, the lacrimal drainage system, and the sclera in patients under 12 years of age. | |
| 215 | 71 | ||
| 216 | - | ||
| 217 | - | ||
| 218 | 72 | (B) Ocular allergies of the anterior segment and adnexa. | |
| 219 | - | ||
| 220 | - | ||
| 221 | 73 | ||
| 222 | 74 | (C) Ocular inflammation, nonsurgical in cause except when comanaged with the treating physician and surgeon, limited to inflammation resulting from traumatic iritis, peripheral corneal inflammatory keratitis, episcleritis, and unilateral nonrecurrent nongranulomatous idiopathic iritis in patients over 18 years of age. | |
| 223 | 75 | ||
| 224 | - | ||
| 225 | - | ||
| 226 | 76 | (D) Traumatic or recurrent conjunctival or corneal abrasions and erosions. | |
| 227 | - | ||
| 228 | - | ||
| 229 | 77 | ||
| 230 | 78 | (E) Nonmalignant ocular surface disease and dry eye disease. | |
| 231 | 79 | ||
| 232 | - | ||
| 233 | - | ||
| 234 | 80 | (F) Ocular pain, nonsurgical in cause except when comanaged with the treating physician and surgeon, associated with conditions optometrists are authorized to treat. | |
| 235 | - | ||
| 236 | - | ||
| 237 | 81 | ||
| 238 | 82 | (G) Hypotrichosis and blepharitis. | |
| 239 | 83 | ||
| 240 | - | ||
| 241 | - | ||
| 242 | - | (H)Pursuant to subdivision (e), glaucoma in patients over 18 years of age, as described in subdivision (k). | |
| 243 | - | ||
| 244 | - | ||
| 84 | + | (H) Pursuant to subdivision (e), glaucoma in patients over 18 years of age, as described in subdivision (j). (k). | |
| 245 | 85 | ||
| 246 | 86 | (2) For purposes of this section, treat means the use of therapeutic pharmaceutical agents, as described in subdivision (c), and the procedures described in subdivision (d). | |
| 247 | 87 | ||
| 248 | - | ||
| 249 | - | ||
| 250 | 88 | (c) In diagnosing and treating the conditions listed in subdivision (b), an optometrist certified to use therapeutic pharmaceutical agents pursuant to Section 3041.3 may use or prescribe, including for rational off-label purposes, all of the following therapeutic pharmaceutical agents: | |
| 251 | - | ||
| 252 | - | ||
| 253 | 89 | ||
| 254 | 90 | (1) Topical pharmaceutical agents for the examination of the human eye or eyes for any disease or pathological condition, including, but not limited to, topical miotics. | |
| 255 | 91 | ||
| 256 | - | ||
| 257 | - | ||
| 258 | 92 | (2) Topical lubricants. | |
| 259 | - | ||
| 260 | - | ||
| 261 | 93 | ||
| 262 | 94 | (3) Antiallergy agents. In using topical steroid medication for the treatment of ocular allergies, an optometrist shall consult with an ophthalmologist if the patients condition worsens 21 days after diagnosis. | |
| 263 | 95 | ||
| 264 | - | ||
| 265 | - | ||
| 266 | 96 | (4) Topical and oral anti-inflammatories. | |
| 267 | - | ||
| 268 | - | ||
| 269 | 97 | ||
| 270 | 98 | (5) Topical antibiotic agents. | |
| 271 | 99 | ||
| 272 | - | ||
| 273 | - | ||
| 274 | 100 | (6) Topical hyperosmotics. | |
| 275 | - | ||
| 276 | - | ||
| 277 | 101 | ||
| 278 | 102 | (7) Topical and oral antiglaucoma agents pursuant to the certification process defined in subdivision (e). | |
| 279 | 103 | ||
| 280 | - | ||
| 281 | - | ||
| 282 | 104 | (8) Nonprescription medications used for the rational treatment of an ocular disorder. | |
| 283 | - | ||
| 284 | - | ||
| 285 | 105 | ||
| 286 | 106 | (9) Oral antihistamines. | |
| 287 | 107 | ||
| 288 | - | ||
| 289 | - | ||
| 290 | 108 | (10) Prescription oral nonsteroidal anti-inflammatory agents. | |
| 291 | - | ||
| 292 | - | ||
| 293 | 109 | ||
| 294 | 110 | (11) Oral antibiotics for medical treatment of ocular disease. | |
| 295 | 111 | ||
| 296 | - | ||
| 297 | - | ||
| 298 | 112 | (12) Topical and oral antiviral medication for the medical treatment of herpes simplex viral keratitis, herpes simplex viral conjunctivitis, periocular herpes simplex viral dermatitis, varicella zoster viral keratitis, varicella zoster viral conjunctivitis, and periocular varicella zoster viral dermatitis. | |
| 299 | - | ||
| 300 | - | ||
| 301 | 113 | ||
| 302 | 114 | (13) Oral analgesics that are not controlled substances. | |
| 303 | 115 | ||
| 304 | - | ||
| 305 | - | ||
| 306 | 116 | (14) Codeine with compounds, hydrocodone with compounds, and tramadol as listed in the California Uniform Controlled Substances Act (Division 10 (commencing with Section 11000) of the Health and Safety Code) and the United States Uniform Controlled Substances Act (21 U.S.C. Sec. 801 et seq.). The use of these agents shall be limited to three days, with a referral to an ophthalmologist if the pain persists. | |
| 307 | - | ||
| 308 | - | ||
| 309 | 117 | ||
| 310 | 118 | (15) Additional therapeutic pharmaceutical agents pursuant to subdivision (f). | |
| 311 | 119 | ||
| 312 | - | ||
| 313 | - | ||
| 314 | 120 | (d) An optometrist who is certified to use therapeutic pharmaceutical agents pursuant to Section 3041.3 may also perform all of the following procedures: | |
| 315 | - | ||
| 316 | - | ||
| 317 | 121 | ||
| 318 | 122 | (1) Corneal scraping with cultures. | |
| 319 | 123 | ||
| 320 | - | ||
| 321 | - | ||
| 322 | 124 | (2) Debridement of corneal epithelia. | |
| 323 | - | ||
| 324 | - | ||
| 325 | 125 | ||
| 326 | 126 | (3) Mechanical epilation. | |
| 327 | 127 | ||
| 328 | - | ||
| 329 | - | ||
| 330 | 128 | (4) Collection of blood by skin puncture or venipuncture for testing patients suspected of having diabetes. | |
| 331 | - | ||
| 332 | - | ||
| 333 | 129 | ||
| 334 | 130 | (5) Suture removal, with prior consultation with the treating physician and surgeon. | |
| 335 | 131 | ||
| 336 | - | ||
| 337 | - | ||
| 338 | 132 | (6) Treatment or removal of sebaceous cysts by expression. | |
| 339 | - | ||
| 340 | - | ||
| 341 | 133 | ||
| 342 | 134 | (7) Administration of oral fluorescein to patients suspected as having diabetic retinopathy. | |
| 343 | 135 | ||
| 344 | - | ||
| 345 | - | ||
| 346 | 136 | (8) Use of an auto-injector to counter anaphylaxis. | |
| 347 | - | ||
| 348 | - | ||
| 349 | 137 | ||
| 350 | 138 | (9) Ordering of smears, cultures, sensitivities, complete blood count, mycobacterial culture, acid fast stain, urinalysis, tear fluid analysis, and X-rays necessary for the diagnosis of conditions or diseases of the eye or adnexa. An optometrist may order other types of images subject to prior consultation with an ophthalmologist or appropriate physician and surgeon. | |
| 351 | 139 | ||
| 352 | - | ||
| 353 | - | ||
| 354 | 140 | (10) A clinical laboratory test or examination classified as waived under the federal Clinical Laboratory Improvement Amendments of 1988 (CLIA) (42 U.S.C. Sec. 263a; Public Law 100-578) and designated as waived in paragraph (9) necessary for the diagnosis of conditions and diseases of the eye or adnexa, or if otherwise specifically authorized by this chapter. | |
| 355 | - | ||
| 356 | - | ||
| 357 | 141 | ||
| 358 | 142 | (11) Punctal occlusion by plugs, excluding laser, diathermy, cryotherapy, or other means constituting surgery as defined in this chapter. | |
| 359 | 143 | ||
| 360 | - | ||
| 361 | - | ||
| 362 | 144 | (12) The use or prescription of diagnostic or therapeutic contact lenses, including lenses or devices that incorporate a medication or therapy the optometrist is certified to prescribe or provide. | |
| 363 | - | ||
| 364 | - | ||
| 365 | 145 | ||
| 366 | 146 | (13) Removal of foreign bodies from the cornea, eyelid, and conjunctiva with any appropriate instrument other than a scalpel. Corneal foreign bodies shall be nonperforating, be no deeper than the midstroma, and require no surgical repair upon removal. | |
| 367 | 147 | ||
| 368 | - | ||
| 369 | - | ||
| 370 | 148 | (14) For patients over 12 years of age, lacrimal irrigation and dilation, excluding probing of the nasal lacrimal tract. The board shall certify any optometrist who graduated from an accredited school of optometry before May 1, 2000, to perform this procedure after submitting proof of satisfactory completion of 10 procedures under the supervision of an ophthalmologist as confirmed by the ophthalmologist. Any optometrist who graduated from an accredited school of optometry on or after May 1, 2000, shall be exempt from the certification requirement contained in this paragraph. | |
| 371 | - | ||
| 372 | - | ||
| 373 | 149 | ||
| 374 | 150 | (15) Intravenous injection for the purpose of performing ocular angiography at the direction of an ophthalmologist as part of an active treatment plan in a setting where a physician and surgeon is immediately available. | |
| 375 | 151 | ||
| 376 | - | ||
| 377 | - | ||
| 378 | 152 | (16) Skin testing to diagnose ocular allergies, limited to the superficial layer of the skin. | |
| 379 | - | ||
| 380 | - | ||
| 381 | 153 | ||
| 382 | 154 | (17) Use of any noninvasive medical device or technology authorized pursuant to subdivision (f). | |
| 383 | 155 | ||
| 384 | - | ||
| 385 | - | ||
| 386 | - | (e)An optometrist certified pursuant to Section 3041.3 shall be certified for the treatment of glaucoma, as described in subdivision (k), in patients over 18 years of age after the optometrist meets the following applicable requirements: | |
| 387 | - | ||
| 388 | - | ||
| 156 | + | (e) An optometrist certified pursuant to Section 3041.3 shall be certified for the treatment of glaucoma, as described in subdivision (j), (k), in patients over 18 years of age after the optometrist meets the following applicable requirements: | |
| 389 | 157 | ||
| 390 | 158 | (1) For licensees who graduated from an accredited school of optometry on or after May 1, 2008, submission of proof of graduation from that institution. | |
| 391 | 159 | ||
| 392 | - | ||
| 393 | - | ||
| 394 | - | (2)For licensees who were certified to treat glaucoma under this section before January 1, 2009, submission of proof of completion of that certification program. | |
| 395 | - | ||
| 396 | - | ||
| 160 | + | (2) For licensees who were certified to treat glaucoma under this section prior to before January 1, 2009, submission of proof of completion of that certification program. | |
| 397 | 161 | ||
| 398 | 162 | (3) For licensees who completed a didactic course of not less than 24 hours in the diagnosis, pharmacological, and other treatment and management of glaucoma, submission of proof of satisfactory completion of the case management requirements for certification established by the board. | |
| 399 | 163 | ||
| 400 | - | ||
| 401 | - | ||
| 402 | 164 | (4) For licensees who graduated from an accredited school of optometry on or before May 1, 2008, and who are not described in paragraph (2) or (3), submission of proof of satisfactory completion of the requirements for certification established by the board under Chapter 352 of the Statutes of 2008. | |
| 403 | 165 | ||
| 404 | - | ||
| 405 | - | ||
| 406 | - | (f)(1)Any topical or oral therapeutic pharmaceutical agent, which is not a controlled substance, or noninvasive medical device or technology that is not expressly authorized for use or prescription by an optometrist certified to use therapeutic pharmaceutical agents pursuant to Section 3041.3 shall be deemed to be authorized if it has received a United States Food and Drug Administration approved indication for the diagnosis or treatment of a condition authorized by this chapter. A licensee shall successfully complete any clinical training imposed by a related manufacturer before using any of those therapeutic pharmaceutical agents or noninvasive medical devices or technologies. | |
| 407 | - | ||
| 408 | - | ||
| 166 | + | (f) (1) Any topical or oral therapeutic pharmaceutical agent, which is not a controlled substance, or noninvasive medical device or technology that is not expressly authorized for use or prescription by an optometrist certified to use therapeutic pharmaceutical agents pursuant to Section 3041.3 shall be deemed to be authorized if it has received a United States Food and Drug Administration approved indication for the diagnosis or treatment of a condition authorized by this chapter. A licensee shall successfully complete any clinical training imposed by a related manufacturer prior to before using any of those therapeutic pharmaceutical agents or noninvasive medical devices or technologies. | |
| 409 | 167 | ||
| 410 | 168 | (2) Any other topical or oral therapeutic pharmaceutical agent, which is not a controlled substance, or noninvasive medical device or technology that is not expressly authorized for use or prescription by an optometrist certified to use therapeutic pharmaceutical agents pursuant to Section 3041.3 and does not meet the requirements in paragraph (1) shall be deemed authorized if approved by the board through regulation for the rational treatment of a condition authorized by this chapter. Any regulation under this paragraph shall require a licensee to successfully complete an appropriate amount of clinical training to qualify to use each topical or oral therapeutic pharmaceutical agent or noninvasive medical device or technology approved by the board pursuant to this paragraph. | |
| 411 | 169 | ||
| 412 | - | ||
| 413 | - | ||
| 414 | 170 | (3) This subdivision shall not be construed to authorize any of the following: | |
| 415 | - | ||
| 416 | - | ||
| 417 | 171 | ||
| 418 | 172 | (A) Any therapeutic pharmaceutical agent, medical device, or technology involving cutting, altering, or otherwise infiltrating human tissue by any means. | |
| 419 | 173 | ||
| 420 | - | ||
| 421 | - | ||
| 422 | 174 | (B) A clinical laboratory test or imaging study not authorized by paragraphs (1) to (16), inclusive, of subdivision (d). | |
| 423 | - | ||
| 424 | - | ||
| 425 | 175 | ||
| 426 | 176 | (C) Treatment of any disease or condition that could not be treated by an optometrist before January 1, 2018. | |
| 427 | 177 | ||
| 428 | - | ||
| 429 | - | ||
| 430 | - | (g)(1)An optometrist certified pursuant to Section 3041.3 shall be certified for the administration of immunizations after the optometrist meets all of the following requirements: | |
| 431 | - | ||
| 432 | - | ||
| 178 | + | (g) (1) An optometrist certified pursuant to Section 3014.3 3041.3 shall be certified for the administration of immunizations after the optometrist meets all of the following requirements: | |
| 433 | 179 | ||
| 434 | 180 | (A) Completes an immunization training program endorsed by the federal Centers for Disease Control and Prevention (CDC) that, at a minimum, includes hands-on injection technique, clinical evaluation of indications and contradications of vaccines, and the recognition and treatment of emergency reactions to vaccines, and maintains that training. | |
| 435 | 181 | ||
| 436 | - | ||
| 437 | - | ||
| 438 | 182 | (B) Is certified in basic life support. | |
| 439 | - | ||
| 440 | - | ||
| 441 | 183 | ||
| 442 | 184 | (C) Complies with all state and federal recordkeeping and reporting requirements, including providing documentation to the patients primary care provided and entering information in the appropriate immunization registry designated by the immunization branch of the State Department of Public Health. | |
| 443 | 185 | ||
| 444 | - | ||
| 445 | - | ||
| 446 | 186 | (D) Applies for an immunization certificate on a board-approved form. | |
| 447 | - | ||
| 448 | - | ||
| 449 | 187 | ||
| 450 | 188 | (2) For the purposes of this section, immunization means the administration of immunizations for influenza, herpes zoster virus, and pneumococcus in compliance with individual Advisory Committee on Immunization Practices (ACIP) vaccine recommendations published by the CDC for persons 18 years of age or older. | |
| 451 | 189 | ||
| 452 | - | ||
| 453 | - | ||
| 454 | 190 | (h) Other than for prescription ophthalmic devices described in subdivision (b) of Section 2541, any dispensing of a therapeutic pharmaceutical agent by an optometrist shall be without charge. | |
| 455 | - | ||
| 456 | - | ||
| 457 | 191 | ||
| 458 | 192 | (i) The practice of optometry does not include performing surgery. Surgery means any procedure in which human tissue is cut, altered, or otherwise infiltrated by mechanical or laser means. Surgery does not include those procedures specified in paragraphs (1) to (15), inclusive, of subdivision (d). This subdivision does not limit an optometrists authority to utilize diagnostic laser and ultrasound technology within his or her scope of practice. | |
| 459 | 193 | ||
| 460 | - | ||
| 461 | - | ||
| 462 | 194 | (j) An optometrist licensed under this chapter is subject to the provisions of Section 2290.5 for purposes of practicing telehealth. | |
| 463 | - | ||
| 464 | - | ||
| 465 | 195 | ||
| 466 | 196 | (k) For purposes of this chapter, glaucoma means either of the following: | |
| 467 | 197 | ||
| 468 | - | ||
| 469 | - | ||
| 470 | 198 | (1) All primary open-angle glaucoma. | |
| 471 | - | ||
| 472 | - | ||
| 473 | 199 | ||
| 474 | 200 | (2) Exfoliation and pigmentary glaucoma. | |
| 475 | 201 | ||
| 476 | - | ||
| 477 | - | ||
| 478 | 202 | (3) (A) Steroid induced glaucoma. | |
| 479 | - | ||
| 480 | - | ||
| 481 | 203 | ||
| 482 | 204 | (B) If an optometrist treats a patient for steroid induced glaucoma the optometrist shall promptly notify the prescriber of the steroid medication if the prescriber did not refer the patient to the optometrist for treatment. | |
| 483 | 205 | ||
| 484 | - | ||
| 485 | - | ||
| 486 | 206 | (l) For purposes of this chapter, adnexa means ocular adnexa. | |
| 487 | - | ||
| 488 | - | ||
| 489 | 207 | ||
| 490 | 208 | (m) In an emergency, an optometrist shall stabilize, if possible, and immediately refer any patient who has an acute attack of angle closure to an ophthalmologist. |